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Abstract
Recombinant bacteria are used for production of human proteins such as the medi-
cal important cytokine Interferon-α-2b (IFN-α-2b). In the present study, Escheri-
achia coli (E.coli) and Cupriavidus necator (C.necator) have been used as expres-
sion hosts for production of human IFN-α-2b. The Pm/XylS expression system,
originating from the Pseudomonas putida TOL plasmid, is used for recombinant
gene expression. A set of expression vectors based on the broad-host-range plas-
mids RK2 or pBBR1, in combination with the Pm/XylS expression cassette, was
constructed. Previous research has identified high-expression variants of regulatory
elements of the Pm/XylS expression cassette, combined these variants and suc-
cessfully obtained high protein expression. In order to evaluate the expression of
IFN-α-2b, a high-expression variant of the Pm/5’UTR element in combination with
a codon-optimized version of the IFN-α-2b gene was compared with the wild-type
Pm/5’UTR variant in combination with a codon-optimized IFN-α-2b gene. In ad-
dition, the expression of IFN-α-2b in the presence/absence of the signal peptide
pelB was evaluated. Soluble and insoluble IFN-α-2b fractions were observed with
both E.coli and C.necator as expression host. However, it was generally detected
higher expression of IFN-α-2b in E.coli than C.necator. Strong expression cassette
elements without pelB were favorable for the expression of soluble IFN-α-2b, while
strong expression cassette elements in combination with pelB promoted the expres-
sion of insoluble IFN-α-2b. For both of the expression hosts, a larger fraction of
the protein was found as insoluble than soluble IFN-α-2b. As far as one knows,
detectable expression of soluble IFN-α-2b is not previously been reported in neither
E.coli nor C.necator. This study has reported clearly detectable levels of soluble
IFN-α-2b in both of these strains.
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Sammendrag
Rekombinante bakterier brukes til produksjon av humane proteiner, blant annet
kan cytokinet Interferon-α-2b (IFN-α-2b) uttrykkes rekombinant i bakterier. I
dette studiet har Escheriachia coli (E.coli) og Cupriavidus necator (C.necator) blitt
brukt som produksjonsverter for ekspresjon av det humane proteinet IFN-α-2b.
Ekspresjonssytemet Pm/XylS, med opprinnelse fra Pseudonomas putida TOL plas-
mid, er brukt for ekspresjon av rekombinant protein. Det ble konstruert en samling
av ekspresjonsvektorer basert på plasmidene RK2 og pBBR1, som begge er funnet
til å fungere i mange bakteriearter, kombinert med ekspresjonskassetten Pm/XylS.
Tidligere forskning har identifisert varianter av Pm og 5’UTR av ekspresjonskasset-
ten Pm/XylS som gir sterkere ekspresjon, kombinert disse elementene, og raportert
om vellykket protein produksjon. For å evaluere ekspresjonen av IFN-α-2b i de to
vertsorganismene, ble varianten av Pm/5’UTR elementet som gir sterk ekspresjon
kombinert med en kodonoptimalisert versjon av IFN-α-2b genet, og sammenlignet
med villtype varienten av Pm/5’UTR kombinert med en kodonoptimalisert versjon
av IFN-α-2b genet. I tillegg ble det testet for ekspresjon ved tilstedeværelse av sig-
nalpeptidet pelB. Det ble detektert produksjon av løselig og ikke-løselig IFN-α-2b
fraksjoner i både E.coli og C.necator. Det ble imidlertid detektert høyere produksjon
av IFN-α-2b i E.coli enn C.necator. Sterk ekspresjonskassett uten pelB ble funnet til
å gi høyest andel løselig protein, mens sterk ekspresjonskassett med pelB ble funnet
til å gi høyest andel ikke-løselig protein. Den største fraksjonen av protein ble funnet
som ikke-løselig IFN-α-2b, noe som var gjeldene for begge produksjonsvertene. Så
vidt man vet er det til nå ikke raportert om detekterbar produksjon av løselig IFN-
α-2b i hverken E.coli eller C.necator. Denne studien har raportert om produksjon
av detekterbare mengder løselig IFN-α-2b i begge de nevnte produksjonsvertene.
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1 Introduction
1.1 Recombinant DNA technology
Biotechnology is defined as the use of any technological application that uses biolog-
ical systems, living organisms, or derivatives thereof, to make or modify products or
processes for specific use (definition by United Nations). Since the early days of biotech-
nology, humans have been manipulating the natural environment to improve the food
supplies, housing and health [13]. Traditional biotechnological products such as bread,
cheese, wine and beer have been made worldwide for centuries using microorganisms
[13]. Today, applications of biotechnology can be divided into several branches, such as
blue (marine), green (agricultural), white (industrial) and red biotechnology (medical),
respectively. Medical biotechnology is especially important for the work presented in this
thesis. This branch may include the use of molecular biology and genetic engineering to
utilize more specific and compatible medicines.
Recombinant DNA technology includes the techniques that are used to separate and re-
combine DNA segments to create recombinant DNA, where the purpose is production of
a desired substance for the harvesting or for the benefit of the host organism itself. The
production of recombinant proteins in bacteria is an important technique within recom-
binant DNA technology. This technique has experienced major improvements the past
decades, allowing us to design plasmid-based vectors by combining DNA elements from
different plasmids to produce recombinant proteins. The use of engineered bacteria, is
increasing productivity and cost-efficiency. It may also improve the protein purity. The
use of recombinant bacteria is beneficial within research, therapy and diagnostics.
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1.2 E.coli as an expression platform for recombinant protein pro-
duction
1.2.1 E.coli as a host
Escherichia coli (E.coli) was discovered in 1885 by Theodor Escherich, and is today
widely used as a bacterial host. It is frequently used as a model organism because of
its well-characterized metabolic, genetic and morphological features. Other advantages
achieved by using E.coli as a host are simple media requirement and fast growth rate.
Many expression systems have been developed for E.coli, enabling a more efficient pro-
duction of recombinant proteins.
However, not all recombinant genes are expressed efficiently in E.coli. The following
factors may all result in less efficient protein expression; mRNA instability, differences
in codon usage, toxicity of gene products, inappropriate protein folding, lack of post-
translational modifications, degradation of the product by the host, and lack of secretion
mechanisms [38]. The choice of bacterial host and expression system may improve some
of these problems. An optimal expression system will have tight control of the expression
at all relevant levels, cheap inducer agents which are not metabolized by the host and that
do not require an uptake system, and be stable during scale up like high-cell-density cul-
tivation [12]. It is also advantageous if the expression system works across species barriers.
1.2.2 Formation of inclusion bodies
High-level expression of human proteins in E.coli often lead to the formation of inclusion
bodies (IB). Formation of IB may occur due to partially unfolded recombinant proteins
which accumulate in the cytoplasm [46]. When being a part of an inclusion body the
protein is neither soluble nor active[46] [22]. Factors which lead to IB formation may
be high protein concentration due to overproduction, reducing environment in the cyto-
plasm, lack of post-translational modifications and improper interactions with enzymes
involved in protein folding [22].
The formation of IB are common when proteins are overexpressed [22], which is a problem
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in recombinant protein expression if the copy number is increased. To be functional the
proteins have to be soluble and biologically active. Methods exist to recover the inclusion
bodies to soluble, active proteins. This involves denaturation and solubilization, plus
renaturation [22]. However, these methods are often inefficient and expensive.
1.2.3 Recombinant proteins to be produced
Expression of recombinant proteins by using E.coli as a host, is demonstrated by the pro-
duction of Interferon-α-2b (IFN-α-2b) in this study. IFN-α-2b belongs to the interferon
family of cytokines. Cytokines are proteins which function as cell signal molecules and
they are part of the human immune response. IFN-α-2b has antiviral, anti-proliferative
and immunomodulatory activities against many mammalian viruses [21]. The protein is
used in the treatment of hepatitis B and C, as well as some types of cancer, such as hairy
cell leukemia [6]. Previous research shows that IFN-α-2b has been expressed recombi-
nantly in E.coli, but with very low expression levels and only insoluble fractions were
detected [50].
mCherry is used as a reporter gene. Reporter genes are often used as an indication of
successful uptake and expression of a certain gene. mCherry is a fluorescent protein used
to visualize expression from the bacteria in vitro [33]. The expression of mCherry is
shown by a pink color of the culture, which easily indicate successful uptake of the plas-
mid carrying mCherry and functional expression from this plasmid, i.e. it demonstrates
a functional expression system.
1.3 Bacterial gene expression
The expression of a gene occurs through transcription and translation. These two pro-
cesses mainly regulate the gene expression, and tightly control of their components may
result in a gene expression system with the preferred characteristics. The important DNA
elements of an expression system are illustrated in Figure 1. This section will give a brief
explanation of how genes are expressed in prokaryotes.
3
1.3.1 The transcriptional process
Transcription may be divided into three major steps: initiation, elongation and termina-
tion. During the initiation step, RNA polymerase recognizes the promoter sequence which
is the start site of the transcription process. In some cases, transcription factors may be
needed to bind the promoter region before the RNA polymerase will recognize it. RNA
polymerase uses the template strand of the DNA to synthesis a complementary mRNA
strand in a 5’ to 3’ direction, through a process called elongation. The RNA polymerase
synthesis mRNA until it reaches a termination signal which triggers the termination step.
Transcription may be regulated by activator and repressor proteins. These proteins are
then bound to the promoter region, and either stimulate (positive regulation) or block
(negative regulation) the binding of RNA polymerase [13].
1.3.2 The translational process
The translation process may also be divided into three major steps, namely initiation,
elongation and termination. Downstream from the promoter sequence is the 5’ untrans-
lated region (5’ UTR). This region is not translated into a protein, but it contains transla-
tional regulatory binding sites, like the Shine-Dalgarno (SD) sequence. The SD sequence
is the ribosomal binding site in bacteria, and it is approximately 9 bp upstream from the
translational start codon.
An open reading frame (ORF) is a DNA sequence that do not contain a translational
stop codon, and hence code for a protein. During the initiation step, the ribosome and
translation factors bind to the SD sequence. The translation starts at the first initation
codon after the SD sequence, which often is AUG. In the elongation step, the mRNA
moves through the ribosome, tRNA recognize complementary codons, and amino acids
are added to a growing chain. The elongation continues until the RNA polymerase
reaches the translational stop codon. In the termination step, release factors bind to the
stop codon and stimulate the release of the polypeptide chain, the ribosome assembly
dissociates and may be reused for translation of another mRNA [13].
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Figure 1: Overview of the gene expression process in prokaryotes. Briefly explained; DNA is
transcribed to give RNA, and RNA is translated into a protein. The figure is adapted from
Clark (2012) [13].
1.4 The RK2 plasmid
The RK2 plasmid is a broad-host-range plasmid, capable of replicating in a large number
of bacterial species [54]. Research has shown that it replicates in many Gram negative
species [47][Vectron unpublished results]. The most essential regions in the RK2 replicon
are the origin of vegetative replication (oriV) and the gene encoding the replication ini-
tiator protein (TrfA) [43]. The TrfA protein binds to iterons in oriV initiating replication
of RK2. Specific mutations in the trfA gene are found to increase the copy number of the
plasmid [20] [26]. The copy-up mutation which is used in this study is termed cop271C,
and results in a copy number of approximately 20 [20] [27]. In fact, copy-up mutations
can increase the copy number up to 24-fold for some plasmids [55]. Changes are that
the higher the copy number of the plasmid is, the higher the protein expression will be [38].
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1.5 The Pm/XylS expression cassette
1.5.1 The TOL plasmid and its transcription factors
The Pm/XylS expression system originate from the toulene-degradative (TOL) plasmid
pWW0 of Pseudomonas putida [24]. The expression system is found to function in a
wide range of bacterial species [9] [19] [10]. The TOL plasmid encodes a pathway for
catabolism of xylenes and toluene [59]. The genes involved are grouped into the upper-
and lower(meta)-pathway operons, positively regulated by XylR and XylS respectively
[12]. XylS belongs to the AraC/XylS family of transcription factors, which are posi-
tive regulators for recombinant gene expression control in bacteria. The expression of
XylS in the lower-pathway is controlled by two individually regulated promoters, Ps1
and Ps2. Ps2 is constitutively expressing low levels of XylS protein monomers. In the
presence of inducer molecules such as benzoic acid derivatives (m-toluate), XylS inter-
acts with the activator, forming dimers. This complex binds the Pm operator, which
initiate transcription from the meta-operon promoter Pm [40]. Dimerization occurs both
in the absence and the presence of an inducer, but to a greater extent in its presence
[18]. The fraction of XylS monomers converted into dimers are unknown. There exist a
maximum concentration level of active dimers inside the cell, and XylS will form inactive
aggregates if the concentration increases beyond this threshold value [61]. Thus, at very
high concentrations of XylS inside the cell, the concentration of dimers will be the same
in the presence and the absence of an inducer. Ps1 is activated by XylR resulting in
transcription of XylS in the presence of pathway substrates (toluene/xylene). XylR also
stimulates transcription from the upper-operon promoter Pu in the presence of pathway
substrates. As noted above, expression from Pm can also be stimulated independently of
the effector molecules if XylS is present in high concentrations. Overproduction of XylS
usually occurs by xylene-activated XylR stimulation of Ps1 [1]. A simplified representa-
tion of the Pm/XylS expression system is illustrated in Figure 2.
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Figure 2: A simplified figurative presentation of the Pm/XylS expression system showing the
transcription process, but not translation. XylS and m-toluic acid form a complex that binds the
Pm operator which results in transcription of a given gene and recombinant protein production.
(Obtained from Vectron Biosolutions).
1.5.2 pJB658-based expression vectors
When combining elements from the TOL plasmid with the RK2 mini replicon, a broad-
host-range vector with a versatile expression cassette is established. This is illustrated
in Figure 3 as pJB658 (also termed pVB1, Vectron unpublished), which was constructed
in 1997 by Blatny and colleagues [11]. It is a modified version of pJB653, with a more
well defined expression system for the use in Gram-negative bacteria. pJB653 was mod-
ified such the position of any cloned gene relative to the promoter and ribosome binding
site was optimized (see Figure 3). The bases that enclosed the ATG (start codon) were
changed by PCR so that new genes to be expressed could be inserted directly into the
ATG downstream of the Pm by digesting with NdeI [11]. The plasmid also contain the
bla gene. This gene produces β-lactamase which lead to bacterial resistance of ampicillin
[37]. The system is especially useful because of its flexible regulation of the Pm promoter
combined with the broad-host-range RK2 plasmid which can function in many Gram
negative bacteria. Moreover, the effectors act in a concentration-dependent manner and
their uptake is based on passive diffusion [49]. The effectors are not metabolized by most
bacteria, which makes the system more useful across species barriers [49].
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Figure 3: Illustration of pJB658, obtained from Blatny (1997) [11]. The plasmid consists of
the Pm promoter upstream from the gene, the xylS gene, the trfA gene, oriV and the bla gene.
pJB658 has been modified further in later studies [50][Vectron unpublished results].
pIFN30SpelB (also termed pAT64) is a pJB658-based vector expressing the codon-optimized
IFN-α-2b protein with pelB signal sequence [50]. The entire gene sequence (originating
from pIFN30pelB) was completely redesigned through complete gene synthesis, resulting
in a codon-optimized gene without any rare codons and a higher GC content than its
parental version [50]. The synthetic gene is 80.4% identical to its parental version, still
maintaining the original sequence of the protein product [50].
1.5.3 The 5’-untranslated region, the Pm promoter
and the xylS gene
Important elements of the Pm/XylS expression cassette are Pm, 5’UTR and xylS. As
previous described, transcription from the meta-operon promoter Pm is stimulated by
the activator protein XylS encoded by the xylS gene. The 5’ untranslated region is critical
for efficient translation and is found to contain the SD sequence. The Pm/XylS promoter
system has been found to be very useful due to its flexible regulation. The Pm promoter
can be regulated by several cheap and harmless effectors, mutations in xylS, 5’UTR and
Pm are found to affect the expression level, and so are different cell growth temperatures
[24] [29] [49].
DNA elements, which are part of the expression system, such as Pm, xylS and 5’UTR,
8
have been mutated and selected for the version with the highest expression. The Pm ver-
sion that lead to the highest expression is a variant called ML2-5 [5], also termed comP
in another study [60]. This variant is found to stimulate higher transcription level, in
addition to increase the final protein expression [60]. A high-expression variant of 5’UTR
is found to be a variant called LIII-3 [7], also termed comU in another study [60]. This
mutation is found to stimulate higher translation of a given gene. The high-expression
variant of xylS is named StEP-13 [57], also termed comX in another study [60]. This
mutation is found to act at the level of transcription, in addition to increasing the final
protein expression.
Increased expression level may also be obtained by combining different evolved DNA
control elements of the expression cassette [60]. The variants with the highest expression
(described above), were combined to determine if a combination would lead to further
improvements [60]. A combination of the two high-expression variants of Pm (comP)
and 5’UTR (comU) in the same expression system (comPU), gave further stimulation of
translation and resulted in higher protein expression. A similar result was obtained for
a combination of the high-expression variant of xylS (comX) and 5’UTR. However, the
comXP combination did not lead to further improvements [60].
The effect of the improved StEP-13 variant of xylS on the expression level has been eval-
uated in several studies [57] [61]. Improved variants of XylS have been obtained by a
combination of error-prone PCR and DNA shuﬄing procedures which resulted in iden-
tification of 13 unique shuﬄed xylS genes [57]. One of these mutant variant is StEP-13,
which contain five amino acid substitutions (F3Y, I50T, F97L, E195G, M196T). In the
work done by Aune and colleagues, the bla gene for ampicillin tolerance under transcrip-
tional control of the Pm promoter functioned as a reporter gene to test for StEP-13
stimulation on the expression level of β-lactamse [57]. The StEP-13 mutant XylS pro-
tein was found to increase the ampicillin tolerance about ninefold compared to wild-type
XylS under induced conditions (1 mM m-toluic acid) [57]. The ampicillin tolerance in the
absence of the inducer was about ninefold higher than wild-type XylS. The production
level of the host-toxic antibody fragment scFv-phOx expressed from Pm with improved
XylS variant, was about nine times higher than when the wild-type XylS was part of the
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expression cassette in the presence of inducer (0.1 mM m-toluic acid) [57].
However, the StEP-13 mutation has later been found only to affect the expression level
from Pm for low and moderate inducer concentrations [61]. Most likely, StEP-13 is not
able to form higher concentrations of active dimers than wild type XylS, but it reaches
the maximum level at lower inducer concentrations. Thus, the maximum concentrations
of active dimers will be unchanged. However, the dimers will form aggregates at lower
XylS concentrations for StEP-13 than for wild type XylS [61].
1.5.4 N-terminal secretion signal sequence
A signal peptide (also called a signal sequence) is an amino acid sequence present at the
N-terminus of a protein. It is usually composed of a short positively charged amino-
terminal domain, followed by a hydrophobic core and neutral amino acids [3] [41]. A
more polar segment is located preceding the cleavage site [3] [41]. The presence of a sig-
nal peptide will facilitate translocation of the protein to the periplasm or the extracellular
medium. The presence of a signal peptide is found to provide several advantages, such
as correct folding, enhanced biological activity, higher product stability and solubility,
and a simplified downstream purification process [38]. On the other hand, accumulation
of protein in the periplasm can also provide reduced folding and formation of inclusion
bodies [38]. Some proteins, including human IFN-α-2b, have a native signal sequence
which naturally translocate the protein when being expressed [25]. IFN-α-2b is secreted
by human lymphocytes during virus infections, and its native secretion sequence of 23
amino acids directs its secretion from the lymphocytes [25].
In addition to work as a fusion partner which facilitate translocation, the presence of
a N-terminal secretion signal peptide has been found to increase the stimulation of the
total expression levels of recombinant proteins in E.coli A frequently applied signal se-
quence is the pelB signal sequence, which is the one used in this study. The pelB gene
encode pectate lysate B, originated from Erwinia carotovora EC [35]. When expressed
recombinantly in E.coli, researchers found that a 22-amino-acid leader peptide had been
removed (pelB signal peptide) [35]. pelB are targeted to the Sec translocation pathway in
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E.coli, which is the most common secretion pathway in this organism [39]. The choice of
signal sequence for high production level and efficient translocation is found to be highly
protein specific and apparently unpredictable in E.coli [49] [50].
A previous study has examined the presence of signal sequences, including pelB, at the
N-terminus of scFv-phOx, GM-CSF and IFN-α-2b when using the pBJ658-based expres-
sion system when producing these proteins recombinantly in E.coli. [50]. No expression
of IFN-α-2b from pIFN30pelB was detected. Thus, a codon-optimized version the IFN-
α-2b gene was introduced into the vector (pIFN30SpelB), which resulted in detectable
production of the protein (40 mg/L). However, all recombinant IFN-α-2b product was
present as inclusion bodies [50]. The presence of pelB was found to increase the expres-
sion of scFv-phOx and GM-CSF as well (without codon-optimized genes).
Not all fusion partners used to stimulate recombinant protein production are protein
translocation signals, such as pelB. For instance, a short DNA sequence corresponding
to the 5’ end of the celB gene, whose protein product is cytosolic, has been found to be
an efficient fusion partner for the expression of IFN-α-2b in E.coli [32]. Kucharova and
colleagues have found that celB can functionally replace pelB as a 5’ fusion partner for
efficient expression of IFN-α-2b. celB of various lengths were tested, and a minimum
of eight codons were found to stimulate expression more efficient than fusion of pelB
[32]. Hence, this suggests that translocation may not be required for efficient expression
of IFN-α-2b. However, the underlying mechanism of how fusion partners work are not
completely clear [32].
1.6 The pBBR1 MCS plasmid
pBBR1 MCS is a 4.7 bp broad-host-range expression vector derived from pBBR1, illus-
trated in Figure 4. pBBR1 was originally isolated from Bordetella bronchisptica and is
found to replicate in a variety of Gram-negative bacteria [2]. Its incompatibility group is
not known [34]. pBBR1 is frequently used for the construction of expression systems such
as pBBR1 MCS and its derivatives. pBBR1 MCS is carrying chloramphenicol resistance,
but there exists antibiotic resistance derivatives which increase the usefulness of this vec-
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tor in Cmr bacteria [31]. pBBR1 MCS backbone combined with the Pm/XylS expression
system is a potentially valuable expression vector for a wide range of Gram-negative
bacteria, including C.necator.
Figure 4: Illustration of the pBBR1 MCS vector carrying the chloramphenicol (cat) gene. Re-
striction sites, mobilization sequences (mob), and the rep gene encoding the replication initiator
protein are shown. Made in Clone Manager 9.
1.7 Cupriavidus necator
1.7.1 Characteristics and metabolic features
Cupriavidus necator (C.necator) (previous named Ralstonia eutropha and Alcaligenes
eutrophus) is an alternative bacterial species which possibly can overcome some of the
disadvantages of using E.coli as recombinant protein expression host. C.necator is a
nonpathogenic Gram-negative bacteria described as a peritrichously flagellated rod. [56].
C.necator has high metabolic diversity and has attracted great interest due to its versatile
metabolic features. One of these features is the ability to efficiently produce polyhydrox-
ybutyrate (PBH), which is of industrial interest [48]. In addition, C.necator has the
ability to grow lithoautotrophically, meaning it can utilize CO2 and H2 as sole carbon
and energy sources in the absence of organic substrates [44] [53]. Moreover, C.necator
can degrade chloroaromatic and chemically related pollutants [53] [44]. Thus, there exists
a well-established starting point for further development of C.necator, which may be a
potentially valuable organism for molecular engineering.
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1.7.2 C.necator as a host
One frequently used strain for molecular engineering is C.necator H16. Up until now,
a number of different expression systems are known to be active in C.necator H16. For
instance prokaryote expression systems based on well-known promoters is known to be
active in C.necator H16. However, they were lacking the ability to be induced due to in-
ability of C.necator H16 to take up the effectors, and/or they exhibited weak activity [17]
[23]. Autonomously replicating expression vectors based on the broad-host-range plas-
mids RP4 (identical to RK2), RSF1010, pBBR1 and pMOL28 are all found to function
in C.necator H16. However, significant plasmid loss for all the expression vectors dur-
ing fermentation in C.necator H16 have been reported [31] [52] [36]. This illustrates the
need for developing an improved expression vector system that fully function in C.necator.
A previous study accomplished by Srinivasan and colleagues, shows that the model pro-
tein organophosphohydrolase (OPH), which traditionally has been expressed as insoluble
protein in E.coli, has been produced at high yield as soluble protein in the correct folded
form in C. necator [52]. Moreover, the Pm/XylS expression system has been found to
be functional in C. necator H1 in the work done by Bi and colleagues [9]. The study
used a pBBR1 MCS-based expression vector combined with a PBAD promoter, which
successfully was transconjugated into C.necator H16 [9]. The PBAD was replaced by the
Pm/XylS expression cassette. Red fluorescent protein (RFP) was used as a reporter gene
and expression of RFP from Pm in the presence and the absence of an inducer was tested.
The expression in presence of inducer was found to be high both for the plasmid carrying
PBAD and Pm/XylS respectively [9]. This is the first demonstration that the Pm/XylS
expression system is functional in C.necator.
1.8 The aim of this study
The aim of this study was to establish functional expression systems to be used in E.coli
and C.necator respectively, in order to utilize these organisms as expression host for
production of the therapeutic protein IFN-α-2b. A set of expression vectors was therefor
designed, based on the broad-host-range plasmids RK2 or pBBR1, all harboring the
13
Pm/XylS expression cassette. The protein production in both E.coli and C.necator was
evaluated to find favorable expression vectors, as well as evaluating the two host organisms
as suitable expression host for the production of soluble IFN-α-2b.
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2 Material and Methods
2.1 Media and solutions
2.1.1 Antibiotics
Final concentration of antibiotics:
100 mg/mL Ampicilin (PanReac AppliChem)
20 mg/mL Chloramphenicol (Sigma)
2.1.2 Growth media
Luria-Bertani (LB) medium
5.0 g Tryptone (OXOID)
2.5 g Yeast extract (OXOID)
5 g NaCl (Merck)
Up to 500 mL dH2O
Autoclaved
LB Agar (LA) medium
5.0 g Tryptone (OXOID)
2.5 g Yeast extract (OXOID)
5 g NaCl (Merck)
7.5 g Agar (OXOID)
Up to 500 mL dH2O
Autoclaved
PSI medium
2.5 g Yeast extract (OXOID)
10 g Tryptone (OXOID)
5.12 g MgSO4·7H2O (VWR)
Up to 500 mL dH2O
pH adjusted to 7.6 using KOH before autoclaving.
Super Optimal Broth (SOB) medium
0.5 g Yeast extract (OXOID)
2 g Tryptone (OXOID)
0.058 g NaCl (Merck)
0.019 g KCl (Merck)
0.50 g MgSO4·7H2O (VWR)
Up to 100 mL dH2O
Autoclaved
Super Optimal Catabolite-repression (SOC) medium
100 mL SOB media
2 mL 20% glucose solution (VWR)
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Basis medium 1+Yeast extract Hi (Hi+YE Basis medium)
Basis medium 1:
The volumes used to make the stock solutions are given in Appendix B.
8.6 g Na2HPO4·2H2O
3 g KH2PO4
1 g NH4Cl
0.5 g NaCl
10 mL Fe(3) citrate hydrate
0.1 mL H3BO3
1.5 mL MnCl2·4H2O
0.1 mL EDTA·2H2O
0.1 mL CuCl2·2H2O
0.1 ml Na2Mo4O4·2H2O
0.1 mL CoCl2·6H2O
2 mL Zn(CH3COO)2·2H2O
Up to 900 mL dH2O
Autoclaved
Yeast extract Hi
10 g yeast extract (OXOID)
Up to 100 mL dH2O
Autoclaved
Basis medium 1 and Yeast extract HI were mixed to make 1 L Hi+Ye Basis medium after
autoclaving.
Nutrient Broth:
2.5 g Peptone
1.5 g meat extract
Up to 500 mL dH2O
pH adujusted to 7.2. Autoclaved.
Nutrient Broth Agar:
2.5 g Peptone
1.5 g meat extract
7.5 g agar
Up to 500 mL dH2O
pH adujusted to 7.2. Autoclaved.
Tryptone soya broth
30 g Tryptone soya broth (Oxoid) in 1L of dH2O.
Autoclaved.
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2.1.3 Other solutions
TFB1, super competent cells:
0.588 g KAc (Potassium acetate) (Merck)
2.42 g RbCl (Rubidium chloride) (ACROS Organics)
0.389 g CaCl2·2H2O (Calcium chloride) (Merck)
3.146 g MnCl2·4H2O (Manganese chloride) (J.T Baker)
30 mL Glycerol (VWR)
Up to 200 mL dH2O
pH adjusted to 5.8 using diluted acetic acis. Sterilized by filtration.
TFB2, super competent cells
0.21 g MOPS (Fisher Scientific)
1.1 g CaCl2·2H2O (Merck)
0.121 g RbCl (ACROS Organics)
15 mL Glycerol (VWR)
Up to 100 mL dH2O
pH adjustedd to 6.5 using diluted NaOH. Sterilized by filtration.
1M MgSO4·7H2O, expression of recombinant proteins
12.3 g MgSO4·7H2O (VWR)
Up to 50 mL dH2O
Glucose solution, expression of recombinant proteins
11.35 g Glucose (VWR)
Up to 50 mL dH2O
Autoclaved
Glycerol solution, expression of recombinant proteins
50.15 g Glycerol (VWR)
Up to 100 mL dH2O
Autoclaved
3×sample buffer, SDS-PAGE
1.5 mL 2M Tris (Sigma)
7.54 g 30% glycerol (VWR)
1.20 g 6% SDS (Merck)
0.06 g 0.3% bromophenolblue (Sigma)
0.93 g 300 mM dithiothereitol (DTT) (VWR)
Up to 20 mL dH2O
2×sample buffer, SDS-PAGE
2× Laemmli Sample Buffer, no1610737 (BioRad)
465 mg DTT (VWR)
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De-staining solution, SDS-PAGE
400 mL MeOH (VWR)
500 mL dH2O
100 mL concentrated AcOH (VWR)
Tris-Buffered Saline (TBS), Western blotting
40 mL 2M Tris base (Sigma)
35.2 g NaCl in 2 L volume (VWR)
pH adjusted to 7.5
TBST, Western blotting
TBS with 0.05% Tween20 (VWR) (500 mL TBS + 250 µL Tween20)
Blotto, Western blotting
3 % skim milk powder (OXOID) in TBS (3 g in 100 mL TBS for each membrane)
Blotting buffer, Western blotting
25 mL 2M Tris base (Sigma)
28.8 g Glycine (VWR)
400 mL Methanol (VWR)
1 g SDS in 2 L volume (Merck)
pH adjusted to 7.5 with HCl
50xTris-acetate-EDTA (50xTAE) buffer, gel electrophoresis
242 g Tris-base (Sigma)
57.1 mL acetic acid (VWR)
100 mL 0.5M EDTA, pH 8 (VWR)
Up to 1000 mL dH2O
Autoclaved
0.8% Agarose solution, gel electrophoresis
3.2 g Agarose (Lonza)
400 mL 1xTAE
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2.2 Bacteria strains and plasmids
The different bacteria strains and plasmids that were used or constructed in this study
are described in Table 2.2. An overview explaining the vector system is given in Table
2.1. All growth media and solutions used in this study are listed in section 2.1. E.coli
DH5α was used as a general cloning host. E.coli DH5α was cultivated in Luria Bertani
(LB) medium or LB Agar medium added a selective antibiotic. Bacteria cultivated in LB
were incubated at 37 ◦C and 225 rpm, while bacteria cultivated in LA were incubated at
37 ◦C and no shaking. The selective antibiotic was chosen based on antibiotic resistance
of the plasmids.
C. necator CCUG 13796, used as an expression host, was cultivated in Nutrient Broth at
37 ◦C and 225 rpm or in Nutrient Broth Agar at 37 ◦and no shaking added appropriate
antibiotic. Wild-type C. necator, which is not harboring recombinant genes, was culti-
vated without antibiotic.
Table 2.1: A guidance explaining the vector system created by Vectron Biosolutions and their
references.
DNA element Properties Reference(s)
Backbone 1: pIFN30SpelB/pAT64 Sletta (2007) [50]
2: pBBR1 MCS Kovach (1994) [30]
Pm/5’UTR A: WT
B: comPU Bakke (2009) [5], Berg (2009) [7], Zwick (2013) [60].
Signal sequence 0: no signal sequence
1: pelB Sletta (2007) [50]
trfA gene B: cop271C Durland (1990) [20], Haugan (1995) [27]
E: not analyzed
xylS gene 0: WT
1: WT
2: StEP-13 Aune 2009 [57]
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2.3 Plasmids constructed
2.3.1 pVB-1B0B1-mCherry (Bakka, 2015)
E.coli DH5α pVB-1B0B1-IL-1RA and E.coli DH5α pVB-1A0B1-mCherry were culti-
vated and plasmids isolated using Miniprep DNA Purification system (Promega). Both
vectors were digested with NdeI and NotI. The 714 bp NdeI/NotI fragment of plasmid
pVB-1B0B1-mCherry was used to substitute for the corresponding fragment of plasmid
pVB-1B0B1-IL-1RA, yielding pVB-1B0B1-mCherry (expressing mCherry).
2.3.2 pVB-1B0B1-IFN-α-2b (Bakka, 2015)
E.coli DH5α pVB-1B0B1-mCherry and E.coli DH5α pVB-1A1B1-IFN-α-2b were culti-
vated and plasmids isolated using Miniprep DNA Purification system (Promega). Both
vectors were digested with NdeI and NotI. The 501 bp NdeI/NotI fragment of plasmid
pVB-1A1B1-IFN-α-2b was used to substitute for the corresponding fragment of plasmid
pVB-1B0B1-mCherry, yielding pVB-1B0B1-IFN-α-2b (expressing IFN-α-2b).
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2.3.3 pVB-1A0B1-IFN-α-2b
E.coli DH5α pVB-1A0B1-mCherry and E.coli DH5α pVB-1B0B1-IFN-α-2b were culti-
vated and plasmids isolated using Miniprep DNA Purification system (Promega). Both
vectors were digested with NdeI and NotI. The 501 bp NdeI/NotI fragment of plasmid
pVB-1B0B1-IFN-α-2b was used to substitute for the corresponding fragment of plasmid
pVB-1A0B1-mCherry, yielding pVB-1A0B1-IFN-α-2b (expressing IFN-α-2b).
Figure 5: Cloning procedure for construction of pVB-1A0B1-IFN-α-2b. pVB-1A0B1-mCherry
and pVB-1B0B1-IFN-α-2b are digested with NdeI and NotI, generating the backbone fragment
1A0B1 and the IFN-α-2b gene, respectively. The fragments are ligated to generate the vector
pVB-1A0B1-IFN-α-2b.
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2.3.4 pVB-1B1B2-IFN-α-2b
E.coli DH5α pVB-1B1B2-IL-1RA and E.coli DH5α pVB-1B0B1-IFN-α-2b were culti-
vated and plasmids isolated using Miniprep DNA Purification system (Promega). Both
vectors were digested with NdeI and NotI. The 501 bp NdeI/NotI fragment of plasmid
pVB-1B0B1-IFN-α-2b was used to substitute for the corresponding fragment of plasmid
pVB-1B1B2-IL-1RA, yielding pVB-1B1B2-IFN-α-2b (expressing IFN-α-2b).
Figure 6: Cloning procedure for construction of pVB-1B1B2-IFN-α-2b. pVB-1B1B2-IL-1RA
and pVB-1B0B1-IFN-α-2b are digested with NdeI and NotI, generating the backbone fragment
1B1B2 and the IFN-α-2b gene, respectively. The fragments are ligated to generate the vector
pVB-1B1B2-IFN-α-2b.
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2.3.5 pVB-1B0B2-IFN-α-2b
E.coli DH5α pVB-1B1B2-IL-1RA and pVB-1B0B1-IL-1RA were cultivated and plasmids
isolated using Miniprep DNA Purification system (Promega). Both vectors were digested
with XbaI and NotI. The 590 bp XbaI/NotI fragment of plasmid pVB-1B0B1-IL-1RA
was used to substitute for the corresponding fragment of plasmid pVB-1B1B2-IL-1RA,
yielding pVB-1B0B2-IL-1RA (expressing IL-1RA). E.coli DH5α pVB-1B0B2-IL-1RA and
E.coli DH5α pVB-1A0B1-IFN-α-2b were cultivated and plasmids isolated. Both vectors
were digested with NdeI and NotI. The 501 bp fragment of plasmid pVB-1A0B1-IFN-α-2b
was used to substitute for the corresponding fragment of plasmid pVB-1B0B2-IL-1RA,
yielding pVB-1B0B2-IFN-α-2b.
Figure 7: Cloning procedure for construction of pVB-1B0B2-IFN-α-2b. pVB-1B1B2-IL-1RA
and pVB-1B0B1-IL-1RA are digested with XbaI and NotI, generating the backbone fragment
1B0B2 and the IL-1RA gene, respectively. The fragments are ligated to generate the vector
pVB-1B0B2-IL-1RA. The vectors pVB-1B0B2-IL-1RA and pVB-1A0B1-IFN-α-2b are digested
by NdeI/NotI, yielding the backbone fragment 1B0B2 and the IFN-α-2b gene. The fragments
are ligated to generate the vector pVB-1B0B2-IFN-α-2b.
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2.3.6 pVB-2A1E0-IFN-α-2b
E.coli DH5α pVB-2A0E0-IFN-α-2b and E.coli DH5α pVB-1A1B1-IFN-α-2b were culti-
vated and plasmids isolated using Miniprep DNA Purification system (Promega). Both
vectors were digested with XbaI and NdeI. The 130 bp XbaI/NdeI fragments of plasmid
pVB-1A1B1-IFN-α-2b was used to substitute for the corresponding fragment of pVB-
2A0E0-IFN-α-2b, yielding pVB-2A1E0-IFN-α-2b.
Figure 8: hei Cloning procedure for construction of pVB-2A1E0-IFN-α-2b. pVB-2A0E0-IFN-
α-2b and pVB-1A1B1-IFN-α-2b are digested with XbaI and NotI, generating the backbone
fragment 2A0E0 and the pelB signal sequence, respectively. The fragments are ligated to gen-
erate the vector pVB-2A1E0-IFN-α-2b.
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2.3.7 pVB-2B0E0-IFN-α-2b
E.coli DH5α pVB-2B1E0-IFN-α-2b and E.coli DH5α pVB-1B0B1-IFN-α-2b were culti-
vated and plasmids isolated using Miniprep DNA Purification system (Promega). Both
vectors were digested with XbaI and NdeI. The 59 bp XbaI/NdeI fragments of plasmid
pVB-1B0B1-IFN-α-2b was used to substitute for the corresponding fragment of pVB-
2B1E0-IFN-α-2b, yielding pVB-2B0E0-IFN-α-2b.
Figure 9: hei Cloning procedure for construction of pVB-2B0E0-IFN-α-2b. pVB-2B1E0-IFN-
α-2b and pVB-1B0B1-IFN-α-2b are digested with XbaI and NotI, generating the backbone
fragment 2B1E0 and the "no-pelB" fragment, respectively. The fragments are ligated to generate
the vector pVB-2B0E0-IFN-α-2b.
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2.4 Methods used for plasmid construction
2.4.1 Super competent cells
Competent cells are treated in a way so they are able to take up naked DNA, through a
process called transformation [8]. Treatment with calcium chloride (CaCl2) has been used
to obtain competent cells for a long time [14] [16]. DNA binds to the cell surface, followed
by uptake through the membrane when CaCl2 are present in high concentration [58] [14].
Treatment with rubidium chloride (RbCl) is an improved method to make chemically
competent cells. In this study, TFB1 and TFB2 are used as treatment solutions (see sec-
tion 2.1). A temperature shock from 0 to 42 degrees, in combination with CaCl2 or other
salts, are found to be an efficient transformation method [8]. The following procedure is
a modified version of the work done by Dagert and Ehrlish [16].
Competent E.coli DH5α cells were incubated in 4 mL LB medium (without antibiotic)
at 37◦C, 225 rotation per minute (rpm) overnight. It was made two parallels. The next
day 0.5 mL of the overnight cultures were used to inoculate 50 mL Psi medium. The
cultures were grown at 37◦C, and OD600 was measured several times to obtain OD600= ∼
0.4 (Unicam Helios epsilon). After about 2 hours, the OD600 was found to be about 4 for
both of the parallels. The samples were incubated on ice for 15 minutes to stop further
growth. Each parallel was transferred to a 50 mL tube and centrifuged at 4500 rpm at
4◦C for 5 minutes (Eppendorf Centrifuge 5804R). The supernatants were discarded and
the pellets resuspended in 20 mL cold TFB1, before incubation on ice for 15 minutes. The
centrifugation was repeated (Eppendorf Centrifuge 5424) and the cells were resuspended
in 1.5 mL cold TFB2. The samples were aliquoted in Eppendorf tubes on ice (100 µL
per tube) and immediately frozen in liquid nitrogen before storage at minus 80◦C.
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2.4.2 Transformation of E.coli DH5α
Transformation is the process where competent cells take up naked DNA, as described in
the past section. The following procedure describes the heat-shock transformation pro-
cess used to transform E.coli. The procedure is adapted from the work done by Dagert
and Ehrlich. [16].
One tube (100 µL) of competent E.coli DH5α cells were thawed on ice. 10 µL of ligation
mix or circular plasmid was added to the thawed cells and gently mixed. The tube was
incubated on ice for 15-30 minutes, the bacteria were heat-shocked in a water bath at
42◦C for 45 seconds, and then transferred to ice and incubated for two minutes. 900
µL pre-warmed SOC medium (37◦C) was added before the cells were incubated at 37◦C
for 1 hour. After incubation, the cells were diluted and plated on LB agar containing a
selective antibiotic for the plasmid. The plates were incubated overnight at 37◦C.
2.4.3 Isolation of plasmid
Isolation of plasmids were performed by using Wizard Plus SV Miniprep DNA Purifica-
tion System (Promega) or Wizard Plus Midiprep DNA Purification System (Promega).
Wizard Plus SV Miniprep DNA Purification System:
1. 4 mL ON culture was centrifuged for 5 minutes at 6000xg (Eppendorf Centrifuge
5804R)
2. The pellet was resuspended with 250 µL Cell Resuspension Solution and transferred
to an Eppendorf tube
3. 250 µL Cell Lysis Solution was added, and the tube was inverted 4 times to obtain
mixing.
4. 10 µL Alkaline Protease Solution was added, the tube was inverted 4 times and
incubated for 5 minutes at room temperature. Alkaline protease inactivates en-
donucloases and other proteins released during the lysis of cells. These proteins
may reduce the quality of isolated plasmid if they don’t get inactivated(Promega).
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5. To neutralize the solution, 350 µL Neutralization Solution was added, then the
tube was inverted 4 times and centrifuged at 13000 rpm for 10 minutes at room
temperature (Eppendorf Centrifuge 5424).
6. A spin column was insertet into a collection tube, and the cleared lysate from the
centrifuged tube was decanted into the spin column.
7. The tube was centrifuged at 13000 rpm for 1 minute at room temperature (Ep-
pendorf Centrifuge 5424). The flow through was discarded and reinserted into the
collection tube.
8. 750 µL Wash Solution was added to the spin column before centrifuged at 13000
rpm for 1 minute (Eppendorf Centrifuge 5424). The flowthrough was discarded and
reinsertedd into the collection tube. The washing procedure was then repeated with
250 µL Wash Solution. Then the tube was centrifuged at 13000 rpm for 2 minutes
at room temperature.
9. The spin column was carefully transfered to a sterile 1.5 mL microcentrifuge tube
without transfering any of the Column Wash Solution with the spin column. 100 µL
Nuclease free water was added to the spin column, and the column was centrifuged
at 13000 rpm for 1 minute at room temperature (Eppendorf Centrifuge 5424).
10. The column was discarded and the DNA in the tube was stored at -20◦C
Wizard Plus Midipreps DNA Purification System:
1. 10-100 mL of cells were harvested by centrifugation at 10,000×g (Eppendorf Cen-
trifuge 5804R)for 10 min at 4◦C. The tube was blotted upside down on a paper to
remove excess liquid.
2. The cell pellet was completely resuspended in 3 mL of Cell Resuspension Solution
3. 3 mL of Cell Lysis Solution was added and mixed by inverting the tube four times.
4. 3 mL Neutralization Solution was added and mixed by inverting the tube four times.
5. The tube was centrifuged 17 14,000×g (Eppendorf Centrifuge 5804R) for 15 minutes
at 4◦C. Pellet for another 15 minutes if the pellet has not formed by the end of
centrifugation.
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6. The supernatant was carefully decanted to a new centrifuge tube, avoiding the white
precipitate.
7. 10 mL of resuspended Wizard Midiprep DNA Purification Resin was added to the
DNA solution and mixed by swirling.
8. For each Midiprep, one Midicolumn was used. The Midicolumn tip was inserted
into the vacuum manifold port (A self-made vacuum pump was used due to no
access to Vac-Man).
9. The resin/DNA mixture was transferred into the Midicolumn. The sample was
vacuumed until all of the sample had passed through the column.
10. 15 mL Column Wash Solution was added to the Midicolumn and a vacuum was
applied to draw the solution through the Midicolumn. The step was repeated.
11. The resin was dried by continuing vacuuming for 30 seconds after the solution
had been pulled through the column. The Midicolumn was removed from the
vacuum source. The Reservoir was separated from the Midicolumn by cutting
with a scissors. The Midicolumn was transferred to a 1.5 mL microcentrifuge for
2 minutes to remove any residual Column Wash Solution. The Midicolumn was
transferred to a new microcentrifuge tube.
12. 300 µL of preheated (60-70◦C) Nuclease-Free Water to the Midicolumn, before
waiting for 1 min. The DNA was eluted by centrifuging the Midicolumn at 10,000×g
for 20 seconds (Eppendorf Centrifuge 5424). The Midicolumn was removed and
discarded.
13. The sample was centrifuged at 10,000×g for 5 minutes to separate residual resin pel-
let from the final eluate. The DNA-containing supernatant was carefully transfered
to a clean microcentrifuge tube.
14. The plasmid DNA was stored at -20◦C
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2.4.4 Measurement of concentration
The plasmid concentrations were determined with Nanodrop Spectrophotometer ND-1000
(Saveen and Werner) by measuring the absorbance at 260 nm.
2.4.5 Digestion of plasmid with restriction enzymes
A restriction enzyme is an endonuclease that recognizes a specific nucleotide sequence
in the DNA and cleave both the DNA strands at that site [51]. A restriction enzyme is
site-specific and only cleave DNA at that restriction site. The restriction enzymes used in
this study are NdeI, NotI and XbaI. NotI and NdeI are originally produced by the bacte-
ria Nocardia ototodis [51]. Restriction sites for all three restriction enzymes are given in
Figure 10. As illustrated in the figure, the cleaving results in sticky ends (5’ overhang).
The procedure used in this study is adopted from New England Biolabs (NEB).
In biotechnology, restriction enzymes are used to isolate specific DNA fragments, such
as a gene. The specific DNA fragment is ligated into a vector, which are cleaved with
the same restriction enzyme(s). The DNA fragments may be further analyzed by gel
electrophoresis.
Figure 10: The restriction sites for NdeI, NotI-HF and XbaI. Digestion with both NdeI, NotI-
HF and XbaI result in sticky ends. (Adapted from NEB).
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Each vector was digested with appropriate restriction enzymes. The digestion mixes used
in this study are listed in Table 2.3. For each vector variant, all the reagents were pipet-
ted into an Eppendorf tube and gently mixed. The samples were incubated at 37◦C for 1
hour. After incubation, 6× loading dye was added to each sample to a final concentration
of 1×. The loading dye is found to stop the enzyme reaction, and in addition give brighter
nucleotide bands (NEB). The DNA fragments were separated by gel electrophoresis.
Table 2.3: A general digestion mix, using NdeI, NotI-HF or XbaI as restiction enzyme(s).
Component Volume digestion Volume control digestion Reference
10x CutSmart Buffer 5 µL 1 µL NEB
Restriction enzyme 1 0.5 µL 0.5 µL NEB
Restriction enzyme 2 0.5 µL 0.5 µL NEB
Vector 20-50 µL 8 µL
dH2O Up to 50 µL
2.4.6 Gel electrophoresis
Gel electrophoresis is a method used to separate DNA molecules by size [13]. The gel
is placed in a buffer-filled tank that has a positive and a negative electrode at opposite
ends, and the DNA samples are loaded into wells in the gel. DNA are negatively charged
molecules, and they will move from the negative electrode toward the positive electrode
when being exposed to an electric current. Thus, larger DNA fragments will move slower
than smaller DNA fragments due to different size [13]. A molecular weight standard with
known band sizes, is used as a reference to determine the size of the DNA fragments.
Figures of the molecular weigh standards used in this study is given in Appendix C. The
gel in this study is made of 0.8% agarose solved in 1xTAE buffer, and added GelRed for
visualizing of the DNA. The gel was run at 90 V for about 90 minutes. GelRed binds to
DNA by intercalation. When exposed to UV light, GelRed will fluoresce [15], and thus
DNA fragments bound to GelRed will be seen as bright bands.
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2.4.7 Extraction of DNA from agarose gel
The DNA fragments were excised from the gel and purified by using Zymoclean Gel DNA
Recovery Kit (Nordic BioSite).
1. The DNA fragment was excised from the agarose gel using a scaple and transferred
into a 1.5 mL microcentrifuge tube.
2. 3 volumes of ADB to each volume of agarose excised from the gel were added to
the tube.
3. The tube with the solution was then incubated at 55◦C for 5-10 minutes until the
gel slice was completely dissolved.
4. The melted agarose solution was transferred to a Zymo Spin Column in a Collection
Tube and centrifuged for 30-60 seconds (Eppendorf Centrifuge 5424). The flow-
through was discarded.
5. 200 µLWash Buffer was added to the column and centrifuged for 30 seconds (Eppen-
dorf Centrifuge 5424). The flow-through was discarded and the washing procedure
repeated.
6. 6-10 µL DNA Elution Buffer was added directly to the column matrix. The column
was transferred into a 1.5 mL tube and centrifuged for 30-60 seconds to elute DNA
(Eppendorf Centrifuge 5424).
2.4.8 Ligation
Ligation of vector a fragment and insert DNA is the last step before construction of the
recombinant plasmid is completed. The enzyme T4 DNA ligase is used to catalyze the
reaction where the vector fragment and the insert DNA are joined together. This is done
by T4 DNA ligase catalyzing linkage between the 3’-OH of one strand and the 5’-PO4 of
the other [13]. The following protocol is based on Ligation Protocol with T4 DNA ligase
from NEB.
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A ligation mix with molar ratio 1:3 vector DNA to insert DNA, is found to be most opti-
mal for successful ligation. An online ligation calculator was used to calculate the molar
ratios based on the indicated size of the DNA fragments (http : //www.insilico.uni −
duesseldorf.de/LigInput.html). The components in the ligation mix were set up in a
microcentrifuge tube on ice where T4 DNA ligase was added last. It was also made a
negative control reaction without insert DNA. The reaction was gently mixed by pipet-
ting up and down and briefly micro-centrifuged. The reaction was incubated at room
temperature for 1-2 hours, or alternatively at 16◦C overnight. After incubation, the reac-
tion was chilled on ice, and 10 µL of the reaction was added into 100 µL competent cells.
The cells were transformed by the heat-shock method, as described in section 2.4.2.
Table 2.4: Components and volumes used for ligation and re-ligation.
Component Liagation Ligation control Reference
10× T4 ligase Buffer 1 µL 1 µL NEB
T4 ligase 1 µL 1 µL NEB
Digested insert x µL No insert
Digested vector y µL y µL
dH2O Up to 10 µL Up to 10 µL
2.4.9 Transformation of C.necator
Electroporation utilizes high-voltage electric shock to introduce DNA into the cells. The
method was first performed by Wong and Neumann in 1982, and the technique has been
generalized and further developed since then [45]. When the cell membrane is exposed to
a high-voltage electric field, it causes a temporary breakdown of the membrane and the
formation of pores, so that DNA can enter the cell [45]. Electroporation of C.necator was
used for uptake of both RK2-based and pBBR1-based expression vectors. The following
procedure is derived from Aneja and colleagues for expression of recombinant protein in
C.necator [1]. The method is further adapted by Vectron Biosolutions.
1. C.necator was directly inoculated from -80◦C and grown in 3 mL Nutrient Broth
overnight at 37◦C and 225 rpm.
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2. 2 mL of this culture was used to inoculate 48 mL Nutrient Broth in a 250 mL
E-flask. The cultures were grown for approximately 3 hours at 37◦C and 225 rpm
until OD600 = 0.4 was obtained.
3. 25 mL × 2 of this culture was centrifuged at 6,000×g at 4◦C for 15 minutes (Ep-
pendorf Centrifuge 5804R). The cells were kept on ice after this step.
4. The harvested cells were resuspended twice (10 mL, then 5 mL by 6,000×g at 4◦C
for 15 minutes (Eppendorf Centrifuge 5804R)) in a prechilled, sterile 0.3 M sucrose
solution (filtered), and the pellet was resuspended in 400 µL 0.3 M sucrose solution.
5. The concentrated cell suspension (100 µ) was mixed with 5 µL transforming plasmid
in an ice-cold Eppendorf tube and incubated on ice for 10 minutes. Note that the
concentration should not exceed 10% of total volume.
6. The transformation mix was transferred to a prechilled electroporation cuvette (0.1
cm gap width). 100 µL concentrated cell suspension was used as a negative control.
Electroporation was performed at 2.5 kV, 25 µF, and 200Ω settings in a Gene Pulser
II electroporator equipped with a Pulse Controller Plus module (BioRad).
7. The cells were well distributed in the cuvette, and the outside of the cuvette was
dried off before it was placed in the electroporator and the "pulse-button" was
pushed. The time constant was recorded (about 4.7 to 4.9)
8. 900 µL pre-warmedd SOC medium was added immediately after electroporation
and the cells were transferred to an Eppendorf tube before incubation for 2 hours
at 37◦C and 225 rpm.
9. The transformants were selected by spreading 100 µL and 900 µL (13000 rpm, 1
min, supernatant removed, 100 µL used for spreading) of the cell suspension on
Nutrient Agar added appropriate antibiotic, followed by 1-2 days incubation at
37◦C.
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2.5 Expression of recombinant proteins in E.coli BL21(DE3)
The production host E.coli BL21(DE3) was transformed to take up vectors harboring
the IFN-α-2b and mCherry genes, respectively. Cultivation of E.coli BL21(DE3), is
under optimal conditions better suited for recombinant protein production than the strain
E.coli DH5α. The following procedure, adapted from Sletta and colleagues, was used
to recombinantly express mCherry and IFN-α-2b in E.coli BL21(DE3) [49] [50]. The
procedure splits up the total protein content of the cell into soluble and insouble protein
fractions.
1. An overnight (ON) culture of BL21(DE3) harboring a recombinant plasmid was
grown in LB containing appropriate antibiotic at 37◦C and 225 rpm.
2. The OD600 value of each culture was determined (Unicam Helios epsilon). The
OD600 measurements were used to calculate the amount of culture needed to give
Hi+YE Basis medium a starting OD600 of 0.05.
3. 600 µL glycerol solution, 240 µL glucose solution and 30 µL ampicilin were added
to 30 mL Hi+YE Basis medium. The amount of culture needed to obtain a starting
OD600 of 0.05, was added to Hi+YE Basis medium. It was executed two parallels
of each culture.
4. The cultures were incubated a 30◦C until OD600 around 2-2.5 was obtained. OD600
above 2 was obtained for all the cultures after 4.5-5 hours incubation.
5. 120 µL 0.5M m-toulate (ALDRICH) was added to one parallel of each culture,
resulting in one induced and one uninduced parallel of each culture. The cultures
were incubated at 25◦C for 16-18 hours.
6. The next day, OD600 of each culture were measured to confirm growth.
7. Each culture was transferred to a 50 mL sterile tube and centrifuged at 10000xg at
4◦C for 10 minutes (Eppendorf Centrifuge 5804R). The supernatants were removed
by vacuuming, and the tubes were weighted to calculate the wet weight of each
pellet.
8. The pellets were transferred to ice and 1 mL/100 mg pellet 0.9% NaCl was added
to each tube. 1 mL of each culture was transferred into a 1.5 mL tube. The samples
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were centrifuged at 13 000 rpm for 5 minutes at 4◦C (Eppendorf Centrifuge 5424).
The supernatants were removed by vacuuming.
9. 500 µL LyticM lysis buffer (Sigma) was added to each sample to resuspend the
pellet. The samples were incubated at room temperature for 1 hour at 100 rpm.
10. The samples were centrifuged at 13000 rpm for 8 minutes (Eppendorf Centrifuge
5424) to separate the soluble protein fraction and the insoluble protein fraction.
11. 400 µL supernatant (soluble fraction) was transferred into a clean 1.5 mL tube. The
remaining supernatant was removed by carefully pipetting. The pellet (insoluble
fraction) was resuspended in 500 µL running buffer (SDS non-reducing running
buffer, C.B.S. Scientific).
2.5.1 Sample preparation for SDS-PAGE
Proteins are usually smaller than DNA molecules, hence polyacrylamide gel electrophore-
sis (PAGE) is better suited to separate proteins by size. Acrylamide has smaller pores
than agarose and is therefor a better choice fir separation of proteins. Moreover, proteins
are not negatively charged and they need to be treated with the negative sodium dodecyl
sulfate (SDS) to obtain a negative charge. SDS unfolds the protein and coat it with
negatively charged SDS molecules. As for agarose gel electrophoresis, the samples are
loaded into the wells, and an electric current is used so that the proteins migrate through
the gel. Then the separated proteins are visualized by Coomassie Blue Staining Solution.
The visual protein bands are compared to a molecular weight standard to determine
their molecule weight (see Appendix D). The following steps was preformed to prepare
the samples for SDS-PAGE [50] [49].
1. The soluble fraction was diluted 2-fold with SDS-running buffer, and the insoluble
fraction was diluted 5-fold with SDS running buffer (SDS non-reducing running
buffer, C.B.S. Scientific).
2. 30 µL diluted sample was combined with 15 µL 3x sample buffer (3xDTT loading
buffer)/30 µL 2x sample buffer (2xDTT loading buffer), and boiled at 99◦C for 5
minutes.
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3. The gel was loaded (5 µL soluble sample, 10 µL insoluble sample and 5 µL molecular
weight standard), and the SDS-PAGE was run at 130 V for 90 minutes.
4. After SDS-PAGE, the gel was stained in BioRad Coomassie stain solution for 30
minutes and then destained overnight.*
5. The next day, the membrane was rehydrated in dH2O for 30 minutes.
*Alternatively, the gel was stained in InstantBlue (a coomassie based staning solution,
Expedoen) for 1 hour and destained in dH2O.
2.5.2 Western-blotting
Western blotting is a method used to detect specific proteins in a sample by using an-
tibodies that binds to the target protein [13]. It also confirms detection of a protein,
and it can be used to estimates the protein expression level. After separation of the
proteins by SDS-PAGE, the proteins are being transfered from the gel to a membrane.
The membrane is positively charged so that the negatively charged proteins will bind to
its surface [13]. The membrane will be exposed to a primary antibody that is used to
locate the target protein. However, areas of the membrane without proteins may bind
non-specifically to the antibody. Non fat milk is often used to block these sites so that
the membrane only can bind target proteins. The secondary antibody is used to recog-
nize and bind to the primary antibody [13]. Also, the secondary antibody has a tag than
easily can be detected. This study use Anti-myc (Invitrogen) as its primary antibody and
Rabbit-anti-mouse Ig HRP (Daco) as its secondary antibody. The genes to be expressed
in this study are marked with a c-myc-His6 tag recognized by the primary antibody. The
following protocol was based on the work done by Sletta and colleagues [49] [50].
1. SDS-PAGE was preformed as described above.
2. The gel, filter paper and blotting sponges were incubated in blotting buffer for 30
minutes. The membrane was incubated in methanol for 15 seconds followed by 2
minutes in dH2O and 10 minutes in blotting buffer.
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3. The set-up for the transfer from gel to membrane was build, blotting buffer added
and the chamber containing the set-up was placed on ice. Then the protein was
transferred from the gel to the membrane with electroblotting at 90 V for 3 hours.*
4. The membrane was washed with TBS for 1 minute. Then the blotted membrane
was blocked in freshly prepared Blotto (30 mL) for 1 hour at room temperature
with constant agitation. Blotto contain skim milk powder that masks the areas of
the membrane without proteins so that they don’t bind the antibody.
5. 3µL primary antibody was diluted in 30 mL Blotto. The membrane was then incu-
bated overnight in Blotto added primary antibody at 4◦C with constant agitation.
6. The next day, the membrane was washed with TBST for 10 minutes 3 times to
remove unbound primary antibody. After washing, the membrane was incubated
in 30 mL Blotto added 15µL secondary antibody for 1 hour in room temperature
with constant agitation.
7. The membrane was washed with TBST for 10 minutes. This step was repeated 2
times before the membrane was rinsed with TBS for 10 minutes.
8. The blot was placed in a clean container and 3 mL substrate Tetramethylbenzidine
(TMB) was added before incubation at room temperature for 1-10 minutes.
9. The blot was rinsed with Mili-Q water to stop the reaction, and the membrane was
scanned.
*Alternatively: The Trans-Blot Transfer System (BioRad) was used for transferring the
protein from the gel to the membrane. (Program used: Mixed molecular weight, 7
minutes).
2.6 Expression of recombinant proteins in C.necator
The following procedure was used for the expression of IFN-α-2b in C.necator. It is
adapted from the work done by Sletta and colleagues [49]. The method differ from
expression in E.coli (Section 2.5) by changes in incubation time and temperature, plus
composition of growth media. Sample preparation for SDS-PAGE and Western blotting
are executed as described Section 2.5.
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1. An ON culture of C.necator harboring a recombinant plasmid was cultivated in
Nutrient Broth containing appropriate antibiotic at 37 ◦C and 225 rpm.
2. The OD600 value of each culture was determined (Unicam Helios epsilon). The
OD600 values were used to calculate the amount of culture needed to give Tryptone
Soya Broth Basis medium a starting OD600 of 0.1 or 0.2.
3. 600 µL glycerol solution, 240 µL glucose solution and 5 µL chloramphenicol in were
added to 30 mL Tryptone Soya Broth. The calculated amount of culture was added
to Tryptone Soya Broth. It was executed two parallels of each culture.
4. The cultures were incubated a 37◦C until OD600 around 2-2.5 was obtained. OD600
above 2 was obtained for all the cultures after approximately 4.5 hours.
5. 120 µL 0.5M m-toulate (ALDRICH) was added to one parallel of each culture,
resulting in one induced and one uninduced parallel of each culture. The cultures
were incubated at 25◦C for 16-18 hours.
6. The next day, OD600 values of each culture was measured to confirm growth.
7. Each culture was transferred to a 50 mL sterile tube and centrifuged at 10000xg at
4◦C for 10 minutes (Eppendorf Centrifuge 5804R). The supernatants were removed
by vacuuming, and the tubes were weighted to calculate the wet weight of each
pellet.
8. The pellets were transferred to ice and 1 mL/100 mg pellet 0.9% NaCl was added
to each tube. 1 mL of each culture was transferred into a 1.5 mL tube. The samples
were centrifuged at 13 000 rpm for 5 minutes at 4◦C (Eppendorf Centrifuge 5424).
The supernatants were removed by vacuuming.
9. 500 µL LyticM lysis buffer (Sigma) was added to each sample to resuspend the
pellet. The samples were incubated at room temperature for 1 hour at 100 rpm.
10. The samples were centrifuged at 13000 rpm for 8 minutes (Eppendorf Centrifuge
5424) to separate the soluble protein fraction and the insoluble protein fraction.
11. 400 µL supernatant (soluble fraction) was transferred into a clean 1.5 mL tube. The
remaining supernatant was removed by carefully pipetting. The pellet (insoluble
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fraction) was resuspended in 500 µL running buffer (SDS non-reducing running
buffer, C.B.S. Scientific).
2.7 mCherry activity
mCherry activity was determined by using an Infinite 200 Pro multifunctional microplate
reader (Tecan) that measures the amount of fluorescent per unit (PFU). E.coli BL21(DE3),
containing vectors expressing mCherry or the negative control pVB1, was cultivated in
LB medium added appropriate antibiotic. SDS sample preparation was performed as de-
scribed in Section 2.5 to obtain induced and uninduced cultures of soluble and insoluble
protein fractions. Each well was loaded with 200 µL culture with excitation and emission
wavelengths of 584 nm (9 nm bandwidth) and 620 nm (20 nm bandwidth) respectively,
and normalized against OD600.
2.8 Quantification of production level
The software GelQuant.net was used for quantification of the production level of IFN-α-
2b.. The software measures the intensity of bands on SDS-PAGE by drawing a selection
rectangle around a segment of the band of interest. By comparing the band intensity of
the molecular mass standard (information on protein amount in the different bands are
given by BioRad) and the band of interest, the total amount of protein in the band can
be calculated. Further, the total amount of mg protein per liter can be estimated, see
Appendix E.
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3 Results
3.1 Construction of expression vectors
Plasmids constructed in this study are described in detail in Section 2.2 and Section 2.3.
The intention of vector construction in this study is to examine different combinations
of DNA elements of the expression cassette, such as the Pm/5’UTR element, the signal
sequence pelB and the xylS gene, to find the best high-expression variant in E.coli and
C.necator respectively. A series of vectors based on pAT64 [Vectron unpublished] was
used as backbone for the construction of vectors for use in E.coli, while pBBR1 MCS [30]
was used as starting point for construction of vectors for use in C.necator.
3.1.1 Construction of pVB-1A0B1-IFN-α-2b
pVB-1A0B1-mCherry and pVB-1B0B1-IFN-α-2b were digested and correctly separated
by gel electrophoresis to achieve the NdeI/NotI backbone fragment (8350 bp) and the
NdeI/NotI IFN-α-2b fragment (501 bp) respectively. The fragments were ligated and suc-
cessfully taken up by E.coli DH5α by transformation. The transformants were cultivated,
plasmids isolated and digested by NdeI/NotI and separated by gel electrophoresis. The
restriction analysis gave the expected separation of 8350 bp and 501 bp. Transformation
of the expression host E.coli BL21(DE3) succeeded in uptake of the constructed vector.
3.1.2 Construction of pVB-1B1B2-IFN-α-2b
pVB-1B1B2-IL-1RA and pVB-1B0B1-IFN-α-2b were digested and correctly separated
by gel electrophoresis to achieve the NdeI/NotI backbone fragment (8417 bp) and the
NdeI/NotI IFN-α-2b fragment (501 bp) respectively. The fragments were ligated and suc-
cessfully taken up by E.coli DH5α by transformation. The transformants were cultivated,
plasmids isolated and digested by NdeI/NotI and separated by gel electrophoresis. The
restriction analysis gave the expected separation of 8417 bp and 501 bp. Transformation
of the expression host E.coli BL21(DE3) succeeded in uptake of the constructed vector.
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3.1.3 Construction of pVB-1B0B2-IFN-α-2b
pVB-1B1B2-IL-1RA and pVB-1B0B1-IL-1RA were digested and correctly separated by
gel electrophoresis to achieve the XbaI/NotI backbone fragment (8289 bp) and the XbaI/NotI
pelB -IL-1RA fragment (521 bp) respectively. The fragments were ligated and successfully
taken up by E.coli DH5α by transformation. The transformants were cultivated, plasmids
isolated and digested by XbaI/NotI and separated by gel electrophoresis. The restriction
analysis gave the expected separation of 8289 bp and 521 bp. The constructed plasmid
pVB-1B0B2-IL-1RA and the plasmid pVB-1A0B1-IFN-α-2b were digested and correctly
separated by gel electrophoresis to achieve the NdeI/NotI backbone fragments (8348 bp)
and the NdeI/NotI IFN-α-2b fragment (501 bp). The fragments were ligated and success-
fully taken up by E.coli DH5α by transformation. The transformants were cultivated,
plasmids isolated and digested by NdeI/NotI and separated by gel electrophoresis. The
restriction analysis gave the expected separation of 8348 bp and 501 bp. Transformation
of the expression host E.coli BL21(DE3) succeeded in uptake of the constructed vector.
3.1.4 Construction of pVB-2A1E0-IFN-α-2b
pVB-2A0E0-IFN-α-2b and pVB-1A1B1-IFN-α-2b were digested and correctly separated
by gel electrophoresis to achieve the XbaI/NdeI backbone fragment (7488 bp) and the
XbaI/NdeI pelB fragment (130 bp) respectively. The fragments were ligated and success-
fully taken up by E.coli DH5α by transformation. The transformants were cultivated,
plasmids isolated and digested by XbaI/NdeI and separated by gel electrophoresis. The
restriction analysis gave the expected separation of 7488 bp and 130 bp. High nucleotide
concentration was required for successful construction due to small DNA fragments.
Transformation of the expression host C.necator succeeded in uptake of the constructed
vector.
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3.1.5 Construction of pVB-2B0E0-IFN-α-2b
pVB-2B1E0-IFN-α-2b and pVB-1B0B1-IFN-α-2b were digested and correctly separated
by gel electrophoresis to achieve the XbaI/NdeI backbone fragment (7547 bp) and the
XbaI/NdeI "no-pelB" fragment (59 bp) respectively. The fragments were ligated and
successfully taken up by E.coli DH5α by transformation. The transformants were culti-
vated, plasmids isolated and digested by XbaI/NdeI and separated by gel electrophore-
sis. The restriction analysis gave the expected separation of 7547 bp and 59 bp. High
nucleotide concentration was required for successful construction due to small DNA frag-
ments. Transformation of the expression host C.necator succeeded in uptake of the
constructed vector.
3.2 Transformation of E.coli
E.coli was transformed using the heat-shock method for uptake of expression vectors (see
Section 3.1), cultivated and selected by its ability to grow on the appropriate antibiotic.
Transformation of E.coli DH5α and E.coli BL21(DE3) with the vectors pVB-1A0B1-
IFN-α-2b, pVB-1B1B2-IFN-α-2b, and pVB-1B0B2-IFN-α-2b all resulted in small, white
colonies. A negative control (not containing the selective gene) was executed for all
transformations and resulted in none or few colonies.
3.3 Growth curve C.necator
A typical bacterial growth curve consists of four phases; lag phase, exponential (log)
phase, stationary phase and death phase. In order to calculate the generation time of
C.necator, the exponential phase was used to calculate the number of times the popula-
tion doubles during a time interval. C.necator was cultivated over night and inoculated
in Nutrient broth the next day. OD600 was measured each hour for about nine hours.
The calculations were executed in three parallels, before finding the average generation
time. Based on this experiment, the generation time was calculated to be 1 hour . A
semi-log plot of the OD600 measurements as a function of time are given in Figure 11.
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Figure 11: Wild-type C.necator CCUG 13796 was cultivated over night in Nutrient Broth
without antibiotic and inoculated the next day. OD600 was measured every hour for about nine
hours. Based on the OD600 measurements, a semi-log plot of OD600 as a function of time, was
generated. The growth curve illustrates the exponential growth phase. OD600 was not measured
at the starting time of the experiment, hence is the lagging phase not included in the figure.
3.4 Transformation of C.necator
C.necator was transformed using the electroporation method (Section 2.4.9) to take up
pAT64-based vectors (pVB-1B1B1-IFN-α-2b, pVB-1B0B1-IFN-α-2b, pVB-1A1B1-IFN-
α-2b, pVB-1A0B1-IFN-α-2b), cultivated and selected by its ability to grow on the ap-
propriate antibiotic. Transformation resulted in no visible colonies.
Due to not successful uptake of pAT64-based vectors, electroporation of C.necator to
take up pBBR1-based vectors (pVB-2A1E0-IFN-α-2b, pVB-2B0E0-IFN-α-2b) was tested.
C.necator was transformed using the electroporation method to take up the given vectors,
cultivated and selected by its ability to grow on the appropriate antibiotic. Transforma-
tion resulted in very small, almost invisible colonies. Extended incubation time (two days
in total) resulted in better growth and small, white colonies.
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3.5 Expression of IFN-α-2b and mCherry in E.coli BL21(DE3)
3.5.1 Expression of IFN-α-2b
E.coli BL21(DE3) was used as expression host for the production of IFN-α-2b in shake
flask cultures. Expression in both the presence and the absence of inducer (2 mM m-
toulate) was tested. Different combinations of expression cassette elements were combined
to find the best high-expression variant. It was also examined how the presence and the
absence of the signal peptide pelB impact the expression level of IFN-α-2b. Expression
from the following vectors, also presented in Table 3.1, was evaluated; pVB-1A0B1-IFN-α-
2b (Pm wild-type, 5’UTR wild-type, no pelB, xylS wild-type), pVB-1A1B1-IFN-α-2b (Pm
wild-type, 5’UTR wild-type, pelB, xylS wild-type), pVB-1B0B1-IFN-α-2b (Pm ML2-5,
5’UTR LIII-3, no pelB, xylS wild-type), pVB-1B1B1-IFN-α-2b (Pm ML2-5, 5’UTR LIII-
3, pelB, xylS wild-type). See Table 2.1 in Section 2.2 for a more thorough explanation
of the vector system. pVB1 was used as a negative control. Expression from the vectors
pVB-1B1B2-IFN-α-2b and pVB-1B0B2-IFN-α-2b was not tested due to time shortage.
Table 3.1: pAT64-based vectors used for expression of IFN-α-2b in E.coli BL21(DE3).
Expression vector
pVB-1A0B1-IFN-α-2b
pVB-1A1B1-IFN-α-2b
pVB-1B0B1-IFN-α-2b
pVB-1B1B1-IFN-α-2b
The expressed proteins were separated into soluble and insoluble fractions, which were
evaluated separately by SDS-PAGE and Western blot analysis (methods described in
Section 2.5.1 and Section 2.5.2). The results are given in Figure 12 and Figure 13 respec-
tively. The codon-optimized IFN-α-2b-c-myc-His6 fusion protein is found to have a mass
of 22.3 kDa. The substrate (TMB) used for protein detection in Figure 12 and Figure
13 was not adopted for use on membranes, and would therefor not stick properly to the
membrane, resulting in blurry pictures.
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Figure 12: SDS-PAGE (a) and Western blot analysis (b) of soluble IFN-α-2b samples obtained
from expression in E.coli BL21(DE3). 5 µL sample were loaded into each well. Lane A: molecular
mass standard; lane B: uninduced pVB-1B1B1-IFN-α-2b; lane C: induced pVB-1B1B1-IFN-α-
2b; lane D: uninduced pVB-1B0B1-IFN-α-2b; lane E: induced pVB-1B0B1-IFN-α-2b; lane F:
uninduced pVB-1A1B1-IFN-α-2b; lane G: induced pVB-1A1B1-IFN-α-2b; lane H: uninduced
pVB-1A0B1-IFN-α-2b; lane I: induced pVB-1A0B1-IFN-α-2b; lane J: uninduced pVB1; lane K:
induced pVB1; lane L: molecular mass standard.
SDS-PAGE of the soluble fractions (Figure 12) indicates high expression of IFN-α-2b from
the vector pVB-1B0B1-IFN-α-2b using E.coliBL21(DE3) as expression host. Expression
of IFN-α-2b is aso observed from the vectors pVB-1A0B1-IFN-α-2b and pVB-1A0B1-
IFN-α-2b. In order to verify the expression of IFN-α-2b, Western blot analysis was
applied. The results confirm highest expression from pVB-1B0B1-IFN-α-2b, as well as
expression from pVB-1A0B1-IFN-α-2b and pVB-1A1B1-IFN-α-2b. The absence of pelB
signal sequence seems to have a positive impact on the production of soluble IFN-α-2b,
which seems to be further increased in combination with a strong expression cassette.
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Figure 13: SDS-PAGE (a) and Western blot analysis (b) of insoluble IFN-α-2b samples ob-
tained from expression in E.coli BL21(DE3). The samples were diluted 5 fold, and 10 µL were
loaded into each well. Lane A: molecular mass standard (5 µL); Lane B: uninduced pVB-
1B1B1-IFN-α-2b; lane C: induced pVB-1B1B1-IFN-α-2b; lane D: uninduced pVB-1B0B1-IFN-
α-2b; lane E: induced pVB-1B0B1-IFN-α-2b; lane F: uninduced pVB-1A1B1-IFN-α-2b; lane
G: induced pVB-1A1B1-IFN-α-2b; lane H: uninduced pVB-1A0B1-IFN-α-2b; lane I: induced
pVB-1A0B1-IFN-α-2b; lane J: uninduced pVB1; lane K: induced pVB1; lane L: molecular mass
standard.
Regarding the insoluble fractions (Figure 13), there was obtained a slimy layer together
with the pellet, making it hard to load the samples into the wells. Thus, the slime was
removed in the cases where this were possible. However, the removal gave some differ-
ences in the total amount of protein loaded on the gel. The SDS-PAGE of the insoluble
fractions indicates high expression of IFN-α-2b from the vectors pVB-1B1B1-IFN-α-2b
and pVB-1A1B1-IFN-α-2b. Western blot analysis was applied and the analysis confirms
high expression from the same vectors. Some expression of IFN-α-2b is also detected
from the vector pVB-1B0B1-IFN-α-2b. The presence of the pelB signal sequence seems
to promote expression of IFN-α-2b, where the expression seems to further increase com-
bined with a strong expression cassette.
The expression of IFN-α-2b in BL21(DE3) in shake flask cultures was repeated to confirm
the results. The experiment was repeated under the same conditions, but no control (i.e.
uninduced cultures) was included. No slime was removed from the insoluble fraction,
giving more comparable bands. The SDS-PAGE and Western blot analysis are given in
Figure 14.
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Figure 14: SDS-PAGE (a) and Western blot analysis (b) of IFN-α-2b samples obtained from
expression in E.coli BL21(DE3). All samples are obtained from induced cultures. Lane B-F:
soluble fractions (5 µL); lane G-K: insoluble fractions (10 µL). Lane A: molecular mass standard;
lane B: pVB-1B1B1-IFN-α-2b soluble fraction; lane C: pVB-1B0B1-IFN-α-2b soluble fraction;
lane D: pVB-1A1B1-IFN-α-2b soluble fraction; lane E: pVB-1A0B1-IFN-α-2b soluble fraction;
lane F: pVB1 soluble fraction; lane G: pVB-1B1B1-IFN-α-2b insoluble fraction; lane H: pVB-
1B0B1-IFN-α-2b insoluble fraction; lane I: pVB-1A1B1-IFN-α-2b insoluble fraction; lane J:
pVB-1A0B1-IFB-α-2b insoluble fraction; lane K: pVB1 insoluble fraction; lane L: molecular
mass standard.
The repeated SDS-PAGE analysis (Figure 14a) is in accordance with the previous ob-
tained results. The new results show high expression of soluble IFN-α-2b from pVB-
1B0B1-IFN-α-2b, and high expression of insoluble IFN-α-2b from pVB-1B1B1-IFN-α-2b
and pVB-1A1B1-IFN-α-2b. The repeated Western blot analysis is also in accordance with
the previous results, and is consistent with the repeated SDS-PAGE. The combination of
a strong expression cassette and no signal sequence seems most likely to be favorable for
high expression of soluble IFN-α-2b, while the combination of a strong expression cassette
and pelB signal sequence seems very likely to trigger expression of insoluble IFN-α-2b in
E.coli BL21(DE3).
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3.5.2 Expression of mCherry
E.coli BL21(DE3) was used as host for the expression of mCherry in shake flask cultures.
Expression in both the presence and the absence of inducer (2 mM m-toulate) was tested.
The expression of mCherry is expected to give the culture a pink color due to fluorescent
characteristics. Thus, mCherry was used as a reporter gene to easily verify a functional
expression system. Different combinations of expression cassette elements were combined
to find the best high-expression variant. It was also examined how the presence and
absence of pelB impact the expression level of mCherry. Expression from the following
vectors, also presented in Table 3.2, was evaluated; pVB-1A0B1-mCherry, pVB-1A1B1-
mCherry, pVB-1B0B1-mCherry and pVB-1B1B1-mCherry (see Section 3.5.1 for vector
description). The expressed proteins were separated into soluble and insoluble fractions,
which were evaluated by SDS-PAGE. The results are given in Figure 16. The codon-
optimized mCherry-c-myc-His6 fusion protein is found to have a mass of 26.7 kDa. The
vector pVB1 was used as a negative control.
Table 3.2: pAT64-based vectors used for expression of mCherry in E.coli BL21(DE3).
Expression vectors
pVB-1A0B1-mCherry
pVB-1A1B1-mCherry
pVB-1B0B1-mCherry
pVB-1B1B1-mCherry
An illustration of the pink color obtained when expressing mCherry is given in Figure 15.
Figure 15: Harvested cells from the expression of mCherry in E.coli BL21(DE3). Illustrates
the pink color obtained when mCherry is being expressed. The expression vector is given below
each tube. UI: uninduced, I: induced.
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Figure 16: SDS-PAGE analysis of soluble mCherry (a) and insoluble mCherry (b) from expres-
sion in BL21(DE3) shake flask cultures. For soluble fraction; 5 µL sample loaded into each well.
For insoluble fraction; 5 fold diluted, 10 µL sample loaded into each well. Lane A: molecular mass
standard; lane B: uninduced pVB-1B1B1- mCherry; lane C: induced pVB-1B1B1-mCherry lane
D: uninduced pVB-1B0B1-mCherry; lane E: induced pVB-1B0B1-mCherry; lane F: uninduced
pVB-1A1B1-mCherry; lane G: induced pVB-1A1B1-mCherry; lane H:uninduced pVB-1A0B1-
mCherry; lane I: induced pVB-1A0B1-mCherry; lane J: uninduced pVB1; lane K: induced pVB1;
lane L: molecular mass standard.
The SDS-PAGE (Figure 16) gave easily detectable bands, which most likely denote ex-
pression of mCherry. Figure 15 presents the cultures after harvesting the cells, where the
pink color clearly indicates expression of mCherry. Hence, Western blot analysis was not
necessary to execute to confirm protein expression. Interestingly, E.coli BL21(DE3) con-
taining pVB-1A1B1-mCherry (Pm wild-type, 5’UTR wild-type, pelB) and pVB-1A0B1-
mCherry (Pm wild-type, 5’UTR wild-type, no pelB) in the presence of inducer gave
the highest expression level in both soluble and insoluble fractions. Relatively strong
bands were also obtained when pVB-1B0B1-mCherry was expressing mCherry (both un-
der uninduced and induced conditions), while expression from pVB-1B1B1-mCherry gave
less detectable bands. Thus, the wild type Pm/5’UTR element seems to give the highest
expression of mCherry in E.coli BL21(DE3). This differ from expression of IFN-α-2b,
where the strong Pm/5’UTR element gave highest expression level. Addition of pelB
signal sequence does not seem to be favorable for expression of mCherry.
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3.6 Expression of IFN-α-2b in C.necator
C.necator was used as host for the expression of IFN-α-2b in shake flask cultures. Expres-
sion in both the presence and the absence of inducer (2 mM m-toulate) was performed.
As described in Section 3.5, different combinations of expression cassette elements and
the signal peptide pelB, were combined to find the best high-expression variant. The
expression from the vectors pVB-2A0E0-IFN-α-2b (Pm wild-type, 5’UTR wild-type, no
pelB, xyls wild-type) and pVB-2B1E0-IFN-α-2b (Pm ML2-5, 5’UTR LIII-3, pelB, xyls
wild-type) was evaluated. The expressed proteins were separated into soluble and insol-
uble fractions and evaluated by SDS-PAGE and Western blot analysis. The results are
given in Figure 17 and Figure 18. Expression from the vectors pVB-2A1E0-IFN-α-2b
and pVB-2B0E0-IFN-α-2b was not performed du to lack of time.
Figure 17: SDS-PAGE analysis of IFN-α-2b expression in C.necator shake flask cultures. The
cultures had a starting OD600 of 0.1. Soluble fractions; lane A-D, 5 µL sample loaded into each
well. Insoluble fractions; lane F-I, 10 µL sample loaded into each well. Lane A: uninduced
pVB-2A0E0-IFN-α-2b; lane B: induced pVB-2A0E0-IFN-α-2b; lane C: uninduced pVB-2B1E0-
IFN-α-2b; lane D: induced pVB-2B1E0-IFN-α-2b; lane E: molecular mass standard; lane F:
uninduced pVB-2A0E0-IFN-α-2b; lane G: induced pVB-2A0E0-IFN-α-2b; lane H: uninduced
pVB-2B1E0-IFN-α-2b; lane I: induced pVB-2B1E0-IFN-α-2b.
Figure 17 presents the SDS-PAGE of C.necator containing the vectors pVB-2A0E0-IFN-
α-2b and pVB-2B1E0-IFN-α-2b. The cultures were inoculated to a starting OD600 of
0.1, and were then incubated at 37 ◦C until OD600 reached 2.0. The growth was consid-
erably slower compared to cultivation of E.coli BL21(DE3) within the same conditions,
even though the incubation temperature was increased. This is most likely due to longer
doubling time (see Figure 11). As presented in Figure 17, there are weak but detectable
bands of soluble IFN-α-2b, while it is hard to observe any detectable bands of insoluble
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IFN-α-2b.
Figure 18: Western blot analysis of IFN-α-2b expression in C.necator shake flask cultures. The
cultures had a starting OD600 of 0.1. Soluble fractions; lane B-E, 5 µL sample loaded into each
well. Insoluble fractions; lane G-I, 10 µL sample loaded into each well. Lane A: molecular mass
standard; lane B: pVB-2A0E0-IFN-α-2b uninduced; lane C: pVB-2A0E0-IFN-α-2b induced;
lane D: pVB-2B1E0-IFN-α-2b uninduced lane E: pVB-2B1E0-IFN-α-2b induced; lane F: molec-
ular mass standard; lane G: pVB-2A0E0-IFN-α-2b uninduced; lane H: pVB-2A0E0-IFN-α-2b
induced; lane I: pVB-2B1E0-IFN-α-2b uninduced; lane J: pVB-2B1E0-IFN-α-2b induced.
To verify the expression of IFN-α-2b, Western blot analysis was performed (Figure 18).
The results show detectable expression of soluble IFN-α-2b from the vectors pVB-2A0E0-
IFN-α-2b (induced) and pVB-2B1B1-IFN-α-2b (uninduced). In addition, the induced
samples from the same vectors confirm expression of insoluble IFN-α-2b. It is important
to note that the insoluble fractions are diluted 5 fold and 10 µL is loaded into each well,
while soluble fractions are undiluted and 5 µL is loaded into each well.
53
3.7 Comparison of expression in E.coli BL21(DE3)
and C.necator
To better evaluate and compare production of IFN-α-2b in E.coli BL21(DE3) and C.necator,
it was executed new SDS-PAGE and Western blot analysis, where samples from both
E.coli and C.necator were included. The expression experiment of IFN-α-2b from C.necator
in shake flask cultures was repeated due to low growth in the previous experiment (Section
3.6). The starting OD600 was set to 0.2, and wild type C.necator was used as a nega-
tive control, as this strain does not harbor the IFN-α-2b gene. Expression from E.coli
BL21(DE3) was not repeated, and induced samples obtained from previous experiment
were used to load the gels (Section 3.5, Figure 14). As previous described, different com-
binations of expression cassette elements were evaluated to find the best high-expression
variant. In addition, comparison of E.coli and C.necator as suitable expression hosts for
the production of IFN-α-2b were evaluated. RK2- and pBBR1-based expression vectors
harboring the same version of expression cassette elements were compared against each
other. The expression from the following vectors, also listed in Table 3.3, was tested;
pVB-2A0E0-IFN-α-2b, pVB-2B1E0-IFN-α-2b, pVB-1A0B1-IFN-α-2b and pVB-1B1B1-
IFN-α-2b (see Section 3.5 and Section 3.6 for descriptions). The expressed proteins were
separated into soluble and insoluble fractions and evaluated by SDS-PAGE and Western
blot analysis. The results are given in Figure 19 (soluble fractions) and Figure 20 (insol-
uble fractions).
Table 3.3: Vectors utilized for comparison of IFN-α-2b production in E.coli BL21(DE3) and
C.necator.
Strain Expression vector
C.necator pVB-2A0E0-IFN-α-2b
C.necator pVB-2B1E0-IFN-α-2b
E.coli BL21(DE3) pVB-1A0B1-IFN-α-2b
E.coli BL21(DE3) pVB-1B1B1-IFN-α-2b
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Figure 19: SDS-PAGE (a) and Western analysis (b) of soluble IFN-α-2b samples obtained
from expression in C.necator shake flask cultures, plus vectors expressed in E.coli BL21(DE3),
harboring the same expression cassette elements. 5 µL sample were loaded into each well.
Starting OD600 of 0.2. Lane A: molecular mass standard; lane B: uninduced pVB-2A0E0-
IFN-α-2b; lane C: induced pVB-2A0E0-IFN-α-2b; lane D: induced pVB-1A0B1-IFN-α-2b; lane
E: uninduced pVB-2B1E0-IFN-α-2b; lane F: induced pVB-2B1E0-IFN-α-2b; lane G: induced
pVB-1B1B1-IFN-α-2b; lane H: uninduced C.necator wild-type (not expressing IFN-α-2b); lane
I: induced C.necator wild-type (not expressing IFN-α-2b); lane J: molecular mass standard.
As shown in Figure 19, it is hard to confirm expression of soluble IFN-α-2b based on
the SDS-PAGE, as all the bands representing IFN-α-2b have low intensity. However,
the Western blot analysis indicates expression of IFN-α-2b from the vectors pVB-2A0E0-
IFN-α-2b, pVB-1A0B1-IFN-α-2b and pVB-1B1B1-IFN-α-2b. The highest expression
level seems to be obtained from pVB-1A0B1-IFN-α-2b.
SDS-PAGE (Figure 20a) of insoluble IFN-α-2b shows very high expression of IFN-α-2b
from the vector pVB-1B1B1-IFN-α-2b. Moreover, the Western blot analysis verifies high
expression from pVB-1B1B1-IFN-α-2b. In addition, expression from the vectors pVB-
2B1E0-IFN-α-2b and pVB-1A0B1-IFN-α-2b was confirmed.
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Figure 20: SDS-PAGE (a) and Western analysis (b) of insoluble IFN-α-2b samples obtained
from expression in C.necator shake flask cultures, plus vectors expressed in E.coli BL21(DE3)
harboring the same expression cassette elements. 10 µL sample were loaded into each well.
Starting OD600 of 0.2. Lane A: molecular mass standard; lane B: uninduced pVB-2A0E0-
IFN-α-2b; lane C: induced pVB-2A0E0-IFN-α-2b; lane D: induced pVB-1A0B1-IFN-α-2b; lane
E: uninduced pVB-2B1E0-IFN-α-2b; lane F: induced pVB-2B1E0-IFN-α-2b; lane G: induced
pVB-1B1B1-IFN-α-2b; lane H: uninduced C.necator wild-type (not expressing IFN-α-2b); lane
I: induced C.necator wild-type (not expressing IFN-α-2b); lane J: molecular mass standard.
Based on the results presented in this section, it seems to be higher expression of IFN-
α-2b in E.coli than C.necator when they are containing vectors with the same Pm/XylS
expression cassette elements. Moreover, it seems to generally be higher protein expression
in E.coli than C.necator, which might, among other reasons, be caused by lower growth
(see Figure 11). Among the results presented in this section, the highest expression of
soluble IFN-α-2b is obtained from E.coli containing pVB-1A0B1-IFN-α-2b, while the
highest expression of insoluble IFN-α-2b is obtained from E.coli containing pVB-1B1B1-
IFN-α-2b. Still, the expression of IFN-α-2b in E.coli and C.necator has consistent trends.
The absence of the signal sequence pelB seems to be favorable for the expression of soluble
IFN-α-2b in both E.coli and C.necator, while the expression of insoluble IFN-α-2b seems
to increase in the presence of pelB. Note that E.coli containing pVB-1B0B1-IFN-α-2b
resulted in higher level of soluble protein than pVB-1A0B1-IFN-α-2b. However, the
combination of strong expression cassette and no pelB was not tested in C.necator.
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3.8 Quantification of production level
One objective of this study was to compare the expression of IFN-α-2b from the individ-
ual vectors and between the two expression hosts. In order to compare the expression
of IFN-α-2b from the individual vectors, quantifications of the bands representing IFN-
α-2b were accomplished. The results obtained in previous sections are hard to quantify
due to very different expression levels. Therefore, the samples were diluted and run on
SDS-PAGE to obtain more comparable results. The results are given in Figure 21, Figure
22 and Figure 23. The calculated production levels are given in Table 3.4. The software
GelQuant.net is used to measure the intensity of SDS-PAGE bands. The area intensity
is used to calculate the total number of mg protein per liter. This is done by comparing
the band intensity of the molecular mass standard (with known protein amounts, infor-
mation on protein amount given by BioRad) and the band of interest. It is advantageous
that the two bands are close in mass weight (kDa) and have comparable band intensities.
For each band used to estimate a production level of IFN-α-2b, the protein amount was
calculated in three parallels before finding the average production level. A more detailed
description of the method is given in Section 2.8 and Appendix E.
3.8.1 Production level of IFN-α-2b in E.coli BL21(DE3)
Figure 21 shows SDS-PAGE and Western blot analysis for expression of IFN-α-2b in
E.coli BL21(DE3). Each sample is diluted to a given level based on previous results (see
Figure 14). As seen in Figure 21, only some of the bands are diluted to the same level
as the molecular mass standard and hence only these bands are quantified. It would
have been favorable to repeat the experiment with more dilutions to get more accurate
quantifications and also quantify more of the samples. However, this was not done due
to lack of time.
57
Figure 21: SDS-PAGE (a) and Western blot analysis (b) for quantification of IFN-α-2b ex-
pression in E.coli BL21(DE3) shake flask cultures. Soluble fractions; lane A-F, 5 µL sample
loaded into each well. Insoluble fractions; lane H-L, 10 µL sample loaded into each well. The
Precision Plus Unstained Standard (BioRad) was used as the molecular mass standard for the
SDS-PAGE. Lane A: pVB-1B1B1-IFN-α-2b undiluted; lane B: pVB-1B0B1-IFN-α-2b 2×diluted;
lane C: pVB-1B0B1-IFN-α-2b 5×diluted; lane D: pVB-1A1B1-IFN-α-2b undiluted; lane E: pVB-
1A0B1-IFN-α-2b undiluted; lane F: pVB-1A0B1-IFN-α-2b 2×diluted; lane G: molecular mass
standard; lane H: pVB-1B1B1-IFN-α-2b 25×diluted; lane I: pVB-1B1B1-IFN-α-2b 50×diluted;
lane J: pVB-1B0B1-IFN-α-2b 5×diluted; lane K: pVB-1A1B1-IFN-α-2b 10×diluted; lane L:
pVB-1A1B1-IFN-α-2b 25×diluted.
The protein bands used for quantification of the production level of IFN-α-2b in E.coli
BL21(DE3), are presented in Figure 21a. The intensity of the bands representing soluble
IFN-α-2b in lane B and C (expressed from pVB-1B0B1-IFN-α-2b) and lane E and F (ex-
pressed from pVB-1A0B1-IFN-α-2b) was measured using GelQuant. The total amount
of IFN-α-2b per liter was calculated, as demonstrated in Appendix E. The protein pro-
duction was calculated to be about 300 mg per liter for both pVB-1B0B1-IFN-α-2b and
pVB-1A0B1-IFN-α-2b, respectively.
The protein bands visualized by Western blotting are compared in relation to each other
(Figure 21b). The highest production of IFN-α-2b is observed when it is expressed from
pVB-1B1B1-IFN-α-2b (strong expression cassette and pelB). Even when diluted 50 times,
the protein sample obtained from this strain shows the highest intensity (Figure 21b lane
I). In general, it is hard to distinguish the band intensities due to few dilutions and hence
58
hard to determine an accurate ratio. Also note that there is high uncertainty in the
method, and the calculated amounts are hence only an estimate. Still, the best vector
expressing soluble IFN-α-2b in E.coli BL21(DE3) was found to be pVB-1B0B1-IFN-α-2b,
and the best vector expressing insoluble IFN-α-2b in E.coli BL21(DE3) was found to be
pVB-1B1B1-IFN-α-2b.
3.8.2 Comparison of the production level of IFN-α-2b in C.necator and
E.coli BL21(DE3)
In order to compare the expression of IFN-α-2b between the two hosts C.necator and
E.coli, SDS-PAGE and Western blot analysis, with samples from both of the hosts, were
performed. The expression of IFN-α-2b from pVB-2A0E0-IFN-α-2b and pVB-2B1E0-
IFN-α-2b in C.necator, and vectors harboring the same combination of expression cas-
sette elements expressed in E.coli (i.e pVB-1A0B1-IFN-α-2b and pVB-1B1B1-IFN-α-2b),
was quantified and compared in relation to each other. The SDS-PAGE and Western blot
analysis of soluble and insoluble fractions are presented on separate gels in Figure 22 and
Figure 23.
The SDS-PAGE given in Figure 22a is used to estimate the production level of soluble
IFN-α-2b in both C.necator and E.coli BL21(DE3). Expression of soluble IFN-α-2b rep-
resented in lane B and C (expressed from pVB-2A0E0-IFN-α-2b in C.necator) and lane
I and J (expressed from pVB-2B1E0-IFN-α-2b in C.necator) was estimated to be about
6 mg/L and 3 mg/L respectively. E.coli BL21(DE3) containing pVB-1A0B1-IFN-α-2b
was estimated to express about 20 mg/L, which is significant more than the expression
level in C.necator. Moreover, when E.coli BL21(DE3) is the expression host, production
of IFN-α-2b from the vector pVB-1A0B1-IFN-α-2b was estimated to be about 20 mg/L
and about 300 mg/L based on separate SDS-PAGE gels (Figure 21 and Figure 22 respec-
tively). Most likely, the real expression level lies somewhere between these two values.
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Figure 22: SDS-PAGE (a) and Western blot analysis (b) for quantification of soluble IFN-α-2b
expression in C.necator shake flask cultures, plus vectors expressed in E.coli BL21(DE3) harbor-
ing the same expression cassette elements. All samples are obtained from induced cultures except
lane I and J, and all lanes are loaded 5 µL. The Precision Plus Unstained Standard (BioRad) was
used as the molecular mass standard for the SDS-PAGE. Lane A: molecular mass standard; lane
B: pVB-2A0E0-IFN-α-2b 2×diluted; lane C: pVB-2A0E0-IFN-α-2b 5×diluted; lane D: pVB-
2A0E0-IFN-α-2b 10×diluted; lane E: pVB-1A0B1-IFN-α-2b 2×diluted; lane F: pVB-1A0B1-
IFN-α-2b 5×diluted; lane G: pVB-1A0B1-IFN-α-2b 10×diluted; lane H: pVB-1A0B1-IFN-α-2b
20×diluted; lane I: uninduced pVB-2B1E0-IFN-α-2b undiluted; lane J: uninduced pVB-2B1E0-
IFN-α-2b 2×diluted; lane K: pVB-1B1B1-IFN-α-2b 2×diluted; lane L: pVB-1B1B1-IFN-α-2b
5×diluted.
The Western blot analysis given in Figure 22b, is comparing the visualized protein bands
in relation to each other. The highest production of soluble IFN-α-2b is observed when it
is expressed from pVB-1A0B1-IFN-α-2b in E.coli, which is in agreement with the quan-
tification analysis. The comparison of soluble fractions indicates that there is 5-10 times
higher production level obtained from E.coli pVB-1A0B1-IFN-α-2b than from C.necator
pVB-2A0E0-IFN-α-2b.
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Figure 23: SDS-PAGE (a) and Western blot analysis (b) for quantification of insolu-
ble IFN-α-2b expression in C.necator shake flask cultures, plus vectors expressed in E.coli
BL21(DE3), harboring the same expression cassette elements. All samples are obtained from
induced cultures and loaded 5 µL. The Precision Plus Unstained Standard (BioRad) was
used as the molecular mass standard for the SDS-PAGE. Lane A: molecular mass standard;
lane B: pVB-2A0E0-IFN-α-2b 5×diluted; lane C: pVB-1A1B1-IFN-α-2b 10×diluted; lane D:
pVB-1A1B1-IFN-α-2b 25×diluted; lane E: pVB-2B1E0-IFN-α-2b 25×diluted; lane F: pVB-
2B1E0-IFN-α-2b 50×diluted; lane G: pVB-2B1E0-IFN-α-2b 75×diluted; lane H: pVB-2B1E0-
IFN-α-2b 100×diluted; lane I: pVB-1B1B1-IFN-α-2b 25×diluted; lane J: pVB-1B1B1-IFN-
α-2b 50×diluted; lane K: pVB-1B1B1-IFN-α-2b 75×diluted; lane L: pVB-1B1B1-IFN-α-2b
100×diluted.
The SDS-PAGE given in Figure 23a is used to estimate the production level of insoluble
IFN-α-2b in both C.necator and E.coli BL21(DE3). The expression of insoluble IFN-α-
2b represented in lane E (expressed from pVB-2B1E0-IFN-α-2b in C.necator) and lane
J and K (expressed from pVB-1B1B1-IFN-α-2b in E.coli BL21(DE3)) was estimated to
be about 80 mg/L and 340 mg/L respectively.
Comparison of insoluble IFN-α-2b based on the Western blot analysis, indicates at least
100 times higher expression in E.coli pVB-1B1B1-IFN-α-2b than in any other of the
expression vectors presented in Figure 23b. As previously known, a larger fraction of
IFN-α-2b is found as insoluble than soluble. Thus, it is expected to obtain higher pro-
duction level of insoluble than soluble IFN-α-2b in both C.necator and E.coli BL21(DE3).
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An overview of the estimated production levels of IFN-α-2b is listed in Table 3.4.
Table 3.4: Estimate of the production levels of recombinant IFN-α-2b protein obtained in
shake flasks cultures of E.coli BL21(DE3) and C.necator respectively.
Strain Plasmid Fraction Production level
[mg/liter]
E.coli BL21(DE3) pVB-1B0B1-IFN-α-2b Soluble 300*
E.coli BL21(DE3) pVB-1A0B1-IFN-α-2b Soluble 150**
E.coli BL21(DE3) pVB-1B1B1-IFN-α-2b Insoluble 340
C.necator pVB-2A0E0-IFNα-2b Soluble 6
C.necator pVB-2B1E0-IFNα-2b Soluble 3
C.necator pVB-2B1E0-IFNα-2b Insoluble 80
*Probably too high due to high uncertainty in the method.
**A mean of two production levels obtained from separate gels are calculated to give a more
reliable estimate.
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3.9 Spectrophotometry analysis of mCherry
A spectrophotometer (Tecan) was used to measure relative fluorescence units (RFU) of
samples obtained from E.coli containing vectors expressing mCherry or the negative con-
trol plasmid pVB1. One expects induced samples to have greater activity than their
corresponding uninduced samples. As described in Section 3.5.2, mCherry was expressed
from the vectors pVB-1A0B1-mCherry, pVB-1A1B1-mCherry, pVB-1B0B1-mCherry, and
pVB-1B1B1-mCherry. Spectrophotometry analysis of soluble and insoluble protein frac-
tions are presented in Figure 24 and Figure 25 respectively.
Figure 24: Activity of soluble mCherry measured by relative fluorescence units.
Spectrophotometry analysis of soluble fractions show that all of the induced samples
have greater activity than their corresponding uninduced samples (Figure 24). The
greatest activity was obtained from E.coli containing pVB-1A1B1-mCherry, while the
lowest activity was obtained from E.coli containing pVB-1B1B1-mCherry. The results
are in agreement with the SDS-PAGE from Section 3.5.2, where cultures containing
pVB-1B1B1-mCherry generate lowest expression, and hence the lowest activity. Cultures
containing pVB-1B0B1-Cherry, pVB-1A1B1-mCherry or pVB-1A0B1-mCherry all have
activity measurements close to each other, which are in agreement with the SDS-PAGE
(Figure 16). However, the greatest activity is observed from the vector pVB-1A1B1-
mCherry.
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Figure 25: Activity of insoluble mCherry measured by relative fluorescence units.
Spectrophotometry analysis of insoluble mCherry fractions show varying results, as pre-
sented in Figure 25. It was obtained higher activity of induced samples than uninduced
samples of E.coli containing pVB-1A1B1-mCherry and pVB-1A0B1-mCherry, which is
exactly as expected. However, it was obtained higher activity of uninduced cultures
containing pVB-1B1B1-mCherry and pVB-1B0B1-mCherry than induced cultures con-
taining the same vectors. Thus, it seems like the improved Pm/5’UTR element has a
negative impact on the mCherry expression, which is in agreement with the SDS-PAGE
(Figure 16).
It is not known why the strong Pm/5’UTR element has a negative impact on the ex-
pression of mCherry, but it might be due to overexpression, which again might cause
stress and eventually cell lysis. Interestingly, it was observed that the induced culture
containing pVB-1B1B1-mCherry had an intense pink color before cell harvesting, but the
resulting protein pellet was observed to be less pink (see Figure 15). The experiment was
repeated to examine if it might be released protein into the supernatant due to cell lysis,
especially in the cases with strong expression cassette elements. Only induced cultures
were tested. Figure 26 represent the results when the activity was measured in soluble
and insoluble fractions, and the supernatant. Figure 27 represent the activity measure-
ment only for the supernatant.
As shown in Figure 26, the activity of the supernatants are relatively low compared to
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Figure 26: Activity of soluble and insoluble mCherry, and the supernatants obtained after cell
harvesting, measured by relative fluorescence units.
the activity of soluble and insoluble mCherry fractions. Figure 27 better illustrates the
internally differences between the supernatants. It is observed highest activity in the
supernatants obtained from cultures containing vectors with strong expression cassette
elements, i.e. the Pm variant ML2-5 and the 5’UTR variant LIII-3. However, the activity
of the supernatant obtained from the culture containing pVB-1A1B1-mCherry is also
found to have an activity above 15000 RFU. Induced cultures containing pVB-1A0B1-
mCherry are found to have the lowest activity of the supernatant The expression from
this vector does also generate high activity of soluble and insoluble mCherry fractions,
which most likely makes this vector the favorable choice for expression of mCherry.
Figure 27: Activity of the supernatants obtained after harvesting the cells. The activity is
measured by relative fluorescence units.
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4 Discussion
4.1 Evaluation of cloning strategies in C.necator
Previous studies have successfully transformed C.necator by transconjugation [9] or biparental-
mating [52]. This study tested electroporation of C.necator uptake of RK2-based expres-
sion vectors, which resulted in no visible colonies. For further work it is suggested that
alternative methods like transconjugation and biparental-mating are executed to test for
uptake of RK2-based vectors by C.necator. Vectron Biosolutions has previously con-
structed pBBR1-based expression vectors and successfully electroporated C.necator for
uptake of these [Vectron unpublished results]. Therefore, several attempts of construction
of pBBR1-based expression vectors were performed, which finally resulted in successful
construction. Due to time shortage, expression of these vectors in C.necator was not
accomplished. For further work it is suggested to test expression of IFN-α-2b from the
pBBR1-based vectors in C.necator.
4.2 Expression of IFN-α-2b in E.coli BL21(DE3)
It was obtained detectable expression of both soluble and insoluble IFN-α-2b in E.coli
BL21(DE3). In order to express high levels of IFN-α-2b, combinations of different ex-
pression cassette elements and presence/absence of the signal peptide pelB were tested.
The presence of the Pm/5’UTR variant comPU was found to give higher expression than
the presence of the corresponding wild-type variant, regarding both insoluble and soluble
fractions. This is in accordance with a previous study by Zwick and colleagues (2103)
that obtained high expression of β-lactamase when combining high-expression variants
of regulatory elements of the Pm/XylS expression cassette [60]. The study states that
the combination of the Pm variant ML2-5, which gives further stimulation of transcrip-
tion [5], and the 5’UTR variant LIII-3, which gives further stimulation of translation
[7], together (termed comPU) gives further stimulation of translation and thus higher
expression levels than for the improved Pm and 5’UTR individually [60].
While the presence of pelB signal peptide does not seem to promote higher expression
of soluble IFN-α-2b, its presence seems to greatly promote higher expression of insoluble
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IFN-α-2b. The greatest expression of insoluble IFN-α-2b is achieved when pelB is present
and in combination with the strong Pm/5’UTR element. Previous research by Sletta and
colleagues (2007) found that the codon-optimized IFN-α-2b gene lead to high production
level for IFN-α-2b in E.coli RV308, but only when pelB was fused to the 5’-terminal end
of the coding region [50]. They obtained a production level of 40 ± 12 mg IFN-α-2b per
liter, but the protein was only present as insoluble fractions [50]. This study is consistent
with the work done by Sletta and colleagues regarding expression of insoluble protein,
where the presence of pelB promote high expression of IFN-α-2b. Moreover, the produc-
tion level detected in this study is much higher than reported in previous studies. As
far as one knows, detectable levels of soluble IFN-α-2b in Ecoli is not reported before.
This study has detected a production level of soluble IFN-α-2b at about 300 mg/L from
the vector harboring the strong Pm/XylS expression cassette element without pelB. Note
that the estimated level of 300 mg/L most likely is higher than the real production level
due to high uncertainty in the quantification method. The software GelQuant.net is used
to estimate the production level by drawing a selection rectangle around a image seg-
ment, hence calculating the area intensity a SDS-PAGE band. However, the calculated
intensity varies according to the size of the selection rectangle set by the user itself, which
gives inaccurate results.
As described above, the presence of pelB signal sequence facilitate translocation of IFN-α-
2b to the periplasm in both of the expression hosts. Hence, expression vectors harboring
pelB is expected to give two bands on the SDS-PAGE and Western blot gels. One band
represents the expression of IFN-α-2b, while the other band represents the cleaved pelB
signal peptide. The expression from vectors harboring the pelB is consistent with the ex-
pected results. However, there is also observed two protein bands from expression vectors
which do not harbor the pelB signal peptide. It is not known what causes the appearance
of the unexpected band. For future work it is suggested to investigate what may cause
the additional band. For instance, it is suggested to run a sequence alignment of the
codon-optimized and the human IFN-α-2b genes to identify differences. It is believed
that the native signal sequence of IFN-α-2b is removed in the codon-optimized version.
However, this may also be confirmed by the sequence alignment.
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Vectors combining the high-expression Pm/5’UTR element and the high-expression vari-
ant of the activator protein gene StEP-13 (also termed comX) were constructed. In co-
operation with Vectron Biosolutions, expression from these vectors were tested in E.coli
BL21(DE3). The Pm variant ML2-5, the 5’UTR variant LIII-3 and the xylS variant
StEP-13 were combined and expression tested in presence and absence of pelB [Vectron
unpublished results]. However, the presence of StEP-13 did not further increase the
expression of IFN-α-2b. This is not in agreement with results obtained by Zwick and col-
leagues (2013), which found that combination of all three high-expression variants lead
to further improvement of protein expression [60]. It might be likely that the presence
of a strong expression cassette may cause an overproduction rate that the cell does not
tolerate, meaning that the cell can not produce more protein above a given level. This
might explain the results obtained by Vectron Biosolutions. Moreover, the StEP-13 mu-
tation has been found only to affect the expression level from Pm for low and moderate
inducer concentrations [61]. The inducer concentration used by Vectron Biosolutions is
2 mM, which is regarded as a relatively high concentration.
4.3 Expression of IFN-α-2b in C.necator
It was obtained detectable expression of both soluble and insoluble IFN-α-2b in C.necator.
As mentioned above, not all expression vectors were tested in C.necator due to time short-
age. The expression of IFN-α-2b from the vector harboring wild-type expression cassette
elements without pelB and the vector harboring strong expression-cassette element with
pelB was evaluated. Wild-type expression cassette elements without pelB resulted in the
highest expression of soluble IFN-α-2b, while strong expression cassette elements with
pelB gave the highest expression of insoluble IFN-α-2b. Previous research have demon-
strated that the Pm/XylS expression cassette function in C.necator, and that expression
in C.necator has resulted in protein in the correct folded way [52] [9] [Vectron/Sintef
unpublsihed results]. This is also demonstrated in this study, showing that C.necator has
the potential to function as an efficient expression host.
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4.4 Comparison of C.necator and E.coli as suitable
expression hosts
The comparison of expression in C.necator and E.coli BL21(DE3), shows that the pro-
duction levels in C.necator are significant lower than production levels obtained in E.coli
BL21(DE3). However, the expression trends in the two hosts are consistent, showing
that the combination of the same expression cassette elements promote expression of
IFN-α-2b in both C.necator and E.coli BL21(DE3). Note that E.coli is a more well-
characterized organism than C.necator, and further characterization of C.necator may
lead to improvement of C.necator as a host organism.
4.5 Conclusion
The production of IFN-α-2b in soluble form in both C.necator and E.coli BL21(DE3) was
achieved. Strong expression cassette elements without pelB signal sequence were favorable
for expression of soluble IFN-α-2b. Insoluble fractions of IFN-α-2b were also obtained,
where strong expression cassette elements in presence of pelB gave the highest expression
of IFN-α-2b. A larger fraction of the protein was found as insoluble than soluble IFN-
α-2b. Generally, it is obtained higher expression of IFN-α-2b in E.coli BL21(DE3) than
C.necator.
4.6 Further work
In the future work it is suggested to test alternative transformation methods of C.necator,
for instance transconjugation or biparental-mating, for uptake of RK2-based vectors. It
is also suggested to test expression from pBBR1-based vectors in C.necator that not were
tested in this study. In addition, testing of more expression cassettes and other signal
peptides, plus optimization of growth conditions such as medium and temperature, may
open up for potential future improvement of expression in C.necator. As previous stated
by Kuscharova and colleagues, the celB fusion partner is found to stimulate expression
of IFN-α-2b in E.coli without translocation of the protein to the periplasm [32]. Hence,
it would be interesting to test fusion of celB to the codon-optimized version of the IFN-
α-2b gene used in this study, and how this impact expression of IFN-α-2b in both E.coli
BL21(DE3) and C.necator. Further investigation of C.necator and future work toward
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even tighter gene expression in this organism may result in a functional expression plat-
form useful for expression of many proteins, including IFN-α-2b.
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A The codon-optimized IFN-α-2b gene
A codon-optimized version of the human IFN-α-2b gene was to used to express IFN-
α-2b-c-myc-His6 in this study. The codon-optimized version is obtained from Vectron
Biosolutions and the sequence is given in Figure 28.
Figure 28: Nucleotide sequence of codon-optimized IFN-α-2b, plus the protein sequence given
in green letterrs. The c-myc-His6 tag is presented after the IFN-α-2b gene. Start codon (ATG)
and stop codon (TGA) is indicated by red boxes. The figure is obtained from the software Clone
Manager 9.
I
B Stock solutions Hi+YE Basis medium
Stock solutions used to make Hi+YE Basis medium for expression of recombinant proteins
in E.coli BL21(DE3) is given in Figure 29.
Figure 29: Stock solutions used to make Hi-YE Basis medium. All stock solutions are pre-made
from Vectron Biosolutions (unknown reference).
II
C Molecular weight standard for
gel electrophoresis
Molecular weight standards with known band sizes were used to determine the size of
DNA fragments separated by gel electrophoresis. Figure 30 and Figure 31 present the
molecular weight standards used in this study. These are from NEB and GeneRuler
respectively.
Figure 30: 1 kb DNA ladder (NEB) visualized by GelRed staining on a 0.8% TAE agarose gel.
Figure 31: 1 kb DNA ladder (GeneRuler) visualized by GelRed staining on a 0.8% TAE agarose
gel.
III
D Molecular weight standard for SDS-PAGE
Molecular weight standards with known band sizes were used to estimate the molecular
weight of the protein bands obtained from SDS-PAGE gel and Western blot, see Figure
32 and Figure 33.
Figure 32: The Precision Plus Protein Standards Dual Color (Bio Rad) was used as a molecular
weight standard for SDS-PAGE and Western blot analysis.
Figure 33: The Precision Plus Protein Unstained Standards (Bio Rad) was used as a molecular
weight standard for SDS-PAGE analysis.
IV
E Quantification of production level
The Software GelQuant.net was used to measure the area intensity of SDS-PAGE bands.
The samples were diluted to obtain similar band intensities as bands of the molecular
weight standard within the same mass range. IFN-α-2b has a mass of 22.3 kDa. Pre-
cision Plus protein amount of the 20 kDa band is given to be 150 ng/10 µL, and the
protein amount of the 25 kDa band is given to be 800 ng/10µL. The Precision Plus pro-
tein amount per 5 µL is 75 ng for the 20 kDa band and 400 ng for the 25 kDa band,
respectively. The area-intensity-ratio between the band of the molecular weight standard
(20 kDa or 25 kDa) and the band of interest (IFN-α-2b) was calculated. The ratio was
multiplied with the given protein amount in the molecular weight standard to find the
total protein amount [ng/5µL] of the band of interest.
ng per 5µL was multiplied by 200 to obtain the protein amount in µg per liter production
culture, before multiplying by 0.001 to obtain the protein amount in mg per liter, as
illustrated below.
ng
5µL
× 1000 µL
mL
= ng
µL
× 200 ng
mL
= ng
mL
= µg
L
µg
L
× 0.001mg
µg
= mg
L
The following factors were considered when finding the original protein amount per liter
production culture
• NaCl concentrating factor X: amount mL NaCl × X = 30 mL production culture,
giving a concentrating factor
X = 30 mL/amount mL NaCl. The protein amount was divided by X.
• 1 mL harvested cells diluted in NaCl was centrifuged and the pellet concentrated
in 500 mL lysis buffer. Thus the protein amount was divided by 2.
• The protein amount was multiplied by a dilution factor Y (Y fold dilution of the
sample), which is individual for each sample.
• Regarding dilution of 30 µL sample in 30 µL sample buffer, the protein amount was
multiplied by 2.
V
F Alternative method: construction of vectors for use
in C.necator
In addition to the construction of pBBR1-based expression vectors by utilizing the di-
gestion/ligation method, the expression vectors pVB-2A1E0-IFN-α-2b and pVB-2B0E0-
IFN-α-2b were also tried constructed by using the Polymerase chain reaction method.
F.1 Polymerase chain reaction (PCR)
PCR is a technique used to amplify the number of copies of a DNA segment in vitro. Two
synthetic oligonucleotides (primers) are prepared, complementary to sequences on oppo-
site strands of the target DNA (template) at positions defining the ends of the segment
to be amplified [42]. The thermostabele Taq DNA polymerase, originating from Thermus
aquaticus, is used for DNA synthesis [42]. The primers used in this study, their sequence
and the complementary templates are listed in Table F.1. The template pBBR1 and the
primers Vf-pBBR1/Vr-pBBR1 are utilized for construction of the backbone fragment.
The templates pVB-1A1B1-IFN-α-2b and pVB-1B0B1-IFN-α-2b are used to create the
"insert", containing the Pm/XylS expression cassette with/without the pelB signal se-
quence, respectively.
Table F.1: PCR primers, their sequences and the corresponding templates used in construction
of pBBR1-based expression vectors.
PCR primer Primer sequence 5’- 3’ Template
Vf-pBBR1 AGCTGTTTCCTGTGTGAATTG pBBR1
Vr-pBBR1 GCGTTAATATTTTGTTAAAATTCGCGTTA pBBR1
1f-pVB-1A0B1-o( CGCAATTTTAACAAAATATTAACGCTGCC pVB-1A1B1-IFN-α-2b/
AACCCATCCCTTCT pVB-1B0B1-IFN-α-2b
1r-pVB-1A0B1-o( AATTTCACACAGGAAACAGCTCAAGCTTG pVB-1A1B1-IFN-α-2b/
CTAGAGGGTCAG pVB-1B0B1-IFN-α-2b
VI
PCR can be divided into the following major steps, which usually are repeated 25-30
times:
• Denaturation: Separation of the DNA template strand by heating, usually up to
94-98◦C.
• Annealing of primers: The temperature is lowered to about 50-56◦C. Single
stranded DNA template is annealed to synthetic oligonucleotide primers.
• DNA synthesis: The temperature is increased to about 75◦C, allowing Taq DNA
polymerase to synthesis DNA in a 5’ to 3’ direction.
The following PCR mix was used, given in Table F.2 All reagents were pipetted into a
PCR tube.
Table F.2: PCR mix used for used for construction of pBBR1-based expression vectors.
Component 1x
5× Q5 buffer 10 µL
Q5 Polymerase 0.5 µL
5× GC enhancer 10 µL
10 mM dNTP 1 µL
dH20 22.5 µL
Primer 1 2.5 µL
Primer 2 2.5 µL
Template 1 µL
The following PCR programs were used for amplification of the backbone fragment and
insert fragments, see Table F.3.
Table F.3: PCR programs used for denaturation of the DNA template, annealing of primers
and DNA synthesis by DNA polymerase.
Program Backbone
Temperature Time
98◦C 30 sec
98◦C 30 sec Repeated
54◦C 30 sec 35×
72◦C 4 min
72◦C 5 min
4◦C hold
Program Insert
Temperature Time
98◦C 30 sec
98◦C 10 sec Repeated
50◦C 30 sec 35×
72◦C 2 min
72◦C 5 min
4◦C hold
VII
Separation of the PCR products by gel electrophoresis, resulted in the correct separation.
The DNA fragments were excised from the gel and assembled using the SLIC protocol,
followed by regular heat-shock transformation.
F.2 One-step sequence- and ligation-independent cloning (SLIC)
The following procedure was performed to assemble the DNA fragments obtained by
PCR [28]. The vector and insert mixture is given in Table F.4. Even though correct the
fragments were obtained when separating the PCR products, the SLIC protocol did not
lead to successful assembling. It is not known why the assembling was unsuccessful.
Table F.4: Mixture for assembling of backbone vector and insert. The amount of vector and
insert is determined by using a ligation calculator.
Components Volume added
Linearized vector x µL
Insert y µL
10× NEB Buffer 2.1 1 µL
dH20 Up tp 10 µL
SLIC protocol:
1. The linearized vector and insert were mixed at a molar ratio of 1:2 in a 1.5 mL
tube, as given in Table F.4.
2. 0.2 µL of T4 DNA polymerase (NEB) was added to the mixture and incubated at
room temperature for 2.5 minutes.
3. The reaction mixture was immediately put on ice to stop the reaction. The mixture
was incubated on ice for 10 minutes.
4. Chemically component E.coli cells were thawed on ice for approximately 10 minutes.
5. For single fragment cloning, the cells were gently mixed with 1-2 µL of the reaction
mixture. For multiple fragments cloning, the cells were gently mixed with with 3-5
µL of the reaction mix.
6. The cells were incubated on ice for 20 minutes.
VIII
7. The cells were heat-shocked at 42◦C for 45 seconds.
8. The cells were incubated on ice for 2 minutes.
9. 900 µL LB broth was added to 100 µL of the cells and transferred to a 15 mL
round-bottom tube.
10. The cells were incubated at 37 ◦for 1 hour.
11. The cells were plated on agar plates containing suitable antibiotics and incubated
at 37◦overnight, before the colonies were analyzed.
IX
